{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Parkinson\u2019s disease", "medicinal plants", "natural products", "neurodegeneration", "neuroinflammation", "pathways", "treatment"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36299886", "DateRevised": {"Year": "2023", "Month": "11", "Day": "06"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "10", "Day": "06"}], "Language": ["eng"], "ELocationID": ["976385", "10.3389/fphar.2022.976385"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "13", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Multifunctional role of natural products for the treatment of Parkinson's disease: At a glance.", "Pagination": {"StartPage": "976385", "MedlinePgn": "976385"}, "Abstract": {"AbstractText": ["Natural substances originating from plants have long been used to treat neurodegenerative disorders (NDs). Parkinson's disease (PD) is a ND. The deterioration and subsequent cognitive impairments of the midbrain nigral dopaminergic neurons distinguish by this characteristic. Various pathogenic mechanisms and critical components have been reported, despite the fact that the origin is unknown, such as protein aggregation, iron buildup, mitochondrial dysfunction, neuroinflammation and oxidative stress. Anti-Parkinson drugs like dopamine (DA) agonists, levodopa, carbidopa, monoamine oxidase type B inhibitors and anticholinergics are used to replace DA in the current treatment model. Surgery is advised in cases where drug therapy is ineffective. Unfortunately, the current conventional treatments for PD have a number of harmful side effects and are expensive. As a result, new therapeutic strategies that control the mechanisms that contribute to neuronal death and dysfunction must be addressed. Natural resources have long been a useful source of possible treatments. PD can be treated with a variety of natural therapies made from medicinal herbs, fruits, and vegetables. In addition to their well-known anti-oxidative and anti-inflammatory capabilities, these natural products also play inhibitory roles in iron buildup, protein misfolding, the maintenance of proteasomal breakdown, mitochondrial homeostasis, and other neuroprotective processes. The goal of this research is to systematically characterize the currently available medications for Parkinson's and their therapeutic effects, which target diverse pathways. Overall, this analysis looks at the kinds of natural things that could be used in the future to treat PD in new ways or as supplements to existing treatments. We looked at the medicinal plants that can be used to treat PD. The use of natural remedies, especially those derived from plants, to treat PD has been on the rise. This article examines the fundamental characteristics of medicinal plants and the bioactive substances found in them that may be utilized to treat PD."], "CopyrightInformation": "Copyright \u00a9 2022 Rahman, Wang, Islam, Akash, Supti, Mitu, Harun-Or-Rashid, Aktar, Khatun Kali, Jahan, Singla, Shen, Rauf and Sharma."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh."}], "LastName": "Rahman", "ForeName": "Md Mominur", "Initials": "MM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China."}], "LastName": "Wang", "ForeName": "Xiaoyan", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh."}], "LastName": "Islam", "ForeName": "Md Rezaul", "Initials": "MR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh."}], "LastName": "Akash", "ForeName": "Shopnil", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh."}], "LastName": "Supti", "ForeName": "Fatema Akter", "Initials": "FA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh."}], "LastName": "Mitu", "ForeName": "Mohona Islam", "Initials": "MI"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh."}], "LastName": "Harun-Or-Rashid", "ForeName": "Md", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh."}], "LastName": "Aktar", "ForeName": "Most Nazmin", "Initials": "MN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh."}], "LastName": "Khatun Kali", "ForeName": "Most Sumaiya", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh."}], "LastName": "Jahan", "ForeName": "Farhana Israt", "Initials": "FI"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China."}, {"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India."}], "LastName": "Singla", "ForeName": "Rajeev K", "Initials": "RK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China."}], "LastName": "Shen", "ForeName": "Bairong", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Swabi, Swabi, Pakistan."}], "LastName": "Rauf", "ForeName": "Abdur", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Rasa Shastra and Bhaishajya Kalpana, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India."}], "LastName": "Sharma", "ForeName": "Rohit", "Initials": "R"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor HB declared a past collaboration with the author RS."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Adepoju G., Odubena O. (2009). Effect of Mucuna pruriens on some haematological and biochemical parameters. J. Med. Plants Res. 3, 73\u201376."}, {"Citation": "Ahmad M., Saleem S., Ahmad A. S., Ansari M. A., Yousuf S., Hoda M. N., et al. (2005). Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats. Hum. Exp. Toxicol. 24, 137\u2013147. 10.1191/0960327105ht509oa", "ArticleIdList": ["10.1191/0960327105ht509oa", "15901053"]}, {"Citation": "Ahmad M., Yousuf S., Khan M. B., Hoda M. N., Ahmad A. S., Ansari M. A., et al. (2006). Attenuation by nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: Behavioral, neurochemical, and immunohistochemical studies. Pharmacol. Biochem. Behav. 83, 150\u2013160. 10.1016/j.pbb.2006.01.005", "ArticleIdList": ["10.1016/j.pbb.2006.01.005", "16500697"]}, {"Citation": "Akhtar M. N., Lam K. W., Abas F., Ahmad S., Shah S. A. A., Choudhary M. I., et al. (2011). New class of acetylcholinesterase inhibitors from the stem bark of Knema laurina and their structural insights. Bioorg. Med. Chem. Lett. 21, 4097\u20134103. 10.1016/j.bmcl.2011.04.065", "ArticleIdList": ["10.1016/j.bmcl.2011.04.065", "21641207"]}, {"Citation": "Altun M. L., Y\u0131lmaz B. S., Orhan I. E., Citoglu G. S. J. I. C. (2013). Assessment of cholinesterase and tyrosinase inhibitory and antioxidant effects of Hypericum perforatum L.(St. John's wort). Industrial Crops Prod. 43, 87\u201392. 10.1016/j.indcrop.2012.07.017", "ArticleIdList": ["10.1016/j.indcrop.2012.07.017"]}, {"Citation": "Amaral de Brito A. P., Galv\u00e3o de Melo I. M. S., El-Bach\u00e1 R. S., Guedes R. C. A. J. F. N. (2020). Valeriana officinalis counteracts rotenone effects on spreading depression in the rat brain in vivo and protects against rotenone cytotoxicity toward rat glioma C6 cells in vitro . Front. Neurosci. 23, 759. 10.3389/fnins.2020.00759", "ArticleIdList": ["10.3389/fnins.2020.00759", "PMC7390944", "32792901"]}, {"Citation": "Amro M., Teoh S., Norzana A., Srijit D. J. L. C. (2018). The potential role of herbal products in the treatment of Parkinson\u2019s disease. Clin. Ter. 169, e23\u2013e33. 10.7417/T.2018.2050", "ArticleIdList": ["10.7417/T.2018.2050", "29446788"]}, {"Citation": "Ardah M. T., Paleologou K. E., Lv G., Menon S. A., Khair S. B. A., Lu J.-H., et al. (2015). Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils. Neurobiol. Dis. 74, 89\u2013101. 10.1016/j.nbd.2014.11.007", "ArticleIdList": ["10.1016/j.nbd.2014.11.007", "PMC4882765", "25449909"]}, {"Citation": "Arenas E. J. (2014). Wnt signaling in midbrain dopaminergic neuron development and regenerative medicine for Parkinson's disease. J. Mol. Cell Biol. 6, 42\u201353. 10.1093/jmcb/mju001", "ArticleIdList": ["10.1093/jmcb/mju001", "24431302"]}, {"Citation": "Arshad L., Haque M. A., Abbas Bukhari S. N., Jantan I. (2017). An overview of structure\u2013activity relationship studies of curcumin analogs as antioxidant and anti-inflammatory agents. Future Med. Chem. 9, 605\u2013626. 10.4155/fmc-2016-0223", "ArticleIdList": ["10.4155/fmc-2016-0223", "28394628"]}, {"Citation": "Asakawa Y., Matsuda R., Takemoto T. J. P. (1982). Mono- and sesquiterpenoids from Hydrocotyle and Centella species. Phytochemistry 21, 2590\u20132592. 10.1016/0031-9422(82)85264-3", "ArticleIdList": ["10.1016/0031-9422(82)85264-3"]}, {"Citation": "Ascherio A., Zhang S. M., Hern\u00e1n M. A., Kawachi I., Colditz G. A., Speizer F. E., et al. (2001). Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann. Neurol. 50, 56\u201363. 10.1002/ana.1052", "ArticleIdList": ["10.1002/ana.1052", "11456310"]}, {"Citation": "Askenasy J., Yahr M. J. N. (1985). Reversal of sleep disturbance in Parkinson's disease by antiparkinsonian therapy: A preliminary study. Neurology 35, 527\u2013532. 10.1212/wnl.35.4.527", "ArticleIdList": ["10.1212/wnl.35.4.527", "3982638"]}, {"Citation": "Auning E., Selnes P., Grambaite R., \u0160altyt\u0117 Benth J., Haram A., L\u00f8vli Stav A., et al. (2015). Neurobiological correlates of depressive symptoms in people with subjective and mild cognitive impairment. Acta Psychiatr. Scand. 131, 139\u2013147. 10.1111/acps.12352", "ArticleIdList": ["10.1111/acps.12352", "25346330"]}, {"Citation": "Axelsen T. M., Woldbye D. P. (2018). Gene therapy for Parkinson\u2019s disease, an update. J. Park. Dis. 8, 195\u2013215. 10.3233/JPD-181331", "ArticleIdList": ["10.3233/JPD-181331", "PMC6027861", "29710735"]}, {"Citation": "Ballard C. G., Jacoby R., Del Ser T., Khan M. N., Munoz D. G., Holmes C., et al. (2004). Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with Lewy bodies. Am. J. Psychiatry 161, 843\u2013849. 10.1176/appi.ajp.161.5.843", "ArticleIdList": ["10.1176/appi.ajp.161.5.843", "15121649"]}, {"Citation": "Barnes J., Anderson L. A., Phillipson J. D. J. J., St John's wort (Hypericum perforatum L. (2001). St john's wort (Hypericum perforatum L.): A review of its chemistry, pharmacology and clinical properties. J. Pharm. Pharmacol. 53, 583\u2013600. 10.1211/0022357011775910", "ArticleIdList": ["10.1211/0022357011775910", "11370698"]}, {"Citation": "Benfica J., Miranda J. S., Morais E. S., Freire M. G., Coutinho J. A., de C\u00e1ssia Superbi de Sousa R. (2020). Enhanced extraction of levodopa from Mucuna pruriens seeds using aqueous solutions of eutectic solvents. ACS Sustain. Chem. Eng. 8, 6682\u20136689. 10.1021/acssuschemeng.0c00196", "ArticleIdList": ["10.1021/acssuschemeng.0c00196"]}, {"Citation": "Berry C., La Vecchia C., Nicotera P. (2010). Paraquat and Parkinson's disease. Cell Death Differ. 17, 1115\u20131125. 10.1038/cdd.2009.217", "ArticleIdList": ["10.1038/cdd.2009.217", "20094060"]}, {"Citation": "Berwick D. C., Harvey K. J. B. S. T. (2012). The importance of Wnt signalling for neurodegeneration in Parkinson's disease. Biochem. Soc. Trans. 40, 1123\u20131128. 10.1042/BST20120122", "ArticleIdList": ["10.1042/BST20120122", "22988876"]}, {"Citation": "Bharate S. B., Sawant S. D., Singh P. P., Vishwakarma R. A. J. C. r. (2013). Kinase inhibitors of marine origin. Chem. Rev. 113, 6761\u20136815. 10.1021/cr300410v", "ArticleIdList": ["10.1021/cr300410v", "23679846"]}, {"Citation": "Bhattacharya T., Chopra H., Rahman M., Hasan Z., Swain S. S., Cavalu S. J. M., et al. (2022). Applications of phyto-nanotechnology for the treatment of neurodegenerative disorders. Materials 15, 804. 10.3390/ma15030804", "ArticleIdList": ["10.3390/ma15030804", "PMC8837051", "35160749"]}, {"Citation": "Boer M. C., Joosten S. A., Ottenhoff T. H. (2015). Regulatory T-cells at the interface between human host and pathogens in infectious diseases and vaccination. Front. Immunol. 6, 217. 10.3389/fimmu.2015.00217", "ArticleIdList": ["10.3389/fimmu.2015.00217", "PMC4426762", "26029205"]}, {"Citation": "Braga-Neto P., da Silva-J\u00fanior F. P., Monte F. S., de Bruin P. F., de Bruin V. M. J. J. (2004). Snoring and excessive daytime sleepiness in Parkinson's disease. J. Neurol. Sci. 217, 41\u201345.", "ArticleIdList": ["14675608"]}, {"Citation": "Brinkhaus B., Lindner M., Schuppan D., Hahn E. J. P. (2000). Chemical, pharmacological and clinical profile of the East Asian medical plant Centella aslatica. Phytomedicine 7, 427\u2013448. 10.1016/s0944-7113(00)80065-3", "ArticleIdList": ["10.1016/s0944-7113(00)80065-3", "11081995"]}, {"Citation": "Brown J. H., Taylor P. (2006). \u201cMuscarinic receptor agonists and antagonists,\u201d in Goodman & gilman's pharmacological basis of therapeutics (New York: McGraw-Hill; ), 183\u2013200."}, {"Citation": "Burn D. J. (2002). Beyond the iron mask: Towards better recognition and treatment of depression associated with Parkinson's disease. Mov. Disord. 17, 445\u2013454. 10.1002/mds.10114", "ArticleIdList": ["10.1002/mds.10114", "12112190"]}, {"Citation": "Burns R. S., Chiueh C. C., Markey S. P., Ebert M. H., Jacobowitz D. M., Kopin I. J. J. P. (1983). A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. Proc. Natl. Acad. Sci. U. S. A. 80, 4546\u20134550. 10.1073/pnas.80.14.4546", "ArticleIdList": ["10.1073/pnas.80.14.4546", "PMC384076", "6192438"]}, {"Citation": "Cassotta M., Geerts H., Harbom L., Outeiro T. F., Pediaditakis I., Reiner O., et al. (2022). The future of Parkinson\u2019s disease research: A new paradigm of human-specific investigation is necessary and possible. ALTEX-Alternatives animal Exp.", "ArticleIdList": ["35404466"]}, {"Citation": "Chalorak P., Jattujan P., Nobsathian S., Poomtong T., Sobhon P., Meemon K. J. N. N. (2018). Holothuria scabra extracts exhibit anti-Parkinson potential in C. elegans: A model for anti-Parkinson testing. Nutr. Neurosci. 21, 427\u2013438. 10.1080/1028415X.2017.1299437", "ArticleIdList": ["10.1080/1028415X.2017.1299437", "28276260"]}, {"Citation": "Chen H.-Q., Jin Z.-Y., Wang X.-J., Xu X.-M., Deng L., Zhao J.-W. J. N. L. (2008). Luteolin protects dopaminergic neurons from inflammation-induced injury through inhibition of microglial activation. Neurosci. Lett. 448, 175\u2013179. 10.1016/j.neulet.2008.10.046", "ArticleIdList": ["10.1016/j.neulet.2008.10.046", "18952146"]}, {"Citation": "Chen X.-C., Chen Y., Zhu Y.-G., Fang F., Chen L.-M. J. A. P. S. (2002). Protective effect of ginsenoside Rg1 against MPTP-induced apoptosis in mouse substantia nigra neurons. Acta Pharmacol. Sin. 23, 829\u2013834.", "ArticleIdList": ["12230953"]}, {"Citation": "Cheng Y.-F., Zhu G.-Q., Wang M., Cheng H., Zhou A., Wang N., et al. (2009). Involvement of ubiquitin proteasome system in protective mechanisms of Puerarin to MPP+-elicited apoptosis. Neurosci. Res. 63, 52\u201358. 10.1016/j.neures.2008.10.009", "ArticleIdList": ["10.1016/j.neures.2008.10.009", "19022306"]}, {"Citation": "Cheng Y., He G., Mu X., Zhang T., Li X., Hu J., et al. (2008). Neuroprotective effect of baicalein against MPTP neurotoxicity: Behavioral, biochemical and immunohistochemical profile. Neurosci. Lett. 441, 16\u201320. 10.1016/j.neulet.2008.05.116", "ArticleIdList": ["10.1016/j.neulet.2008.05.116", "18586394"]}, {"Citation": "Chia S. J., Tan E.-K., Chao Y.-X. (2020). Historical perspective: Models of Parkinson\u2019s disease. Int. J. Mol. Sci. 21, 2464. 10.3390/ijms21072464", "ArticleIdList": ["10.3390/ijms21072464", "PMC7177377", "32252301"]}, {"Citation": "Choi J. G., Park G., Kim H. G., Oh D.-S., Kim H., Oh M. S. J. I. J. M. S. (2016). In vitro and in vivo neuroprotective effects of walnut (Juglandis semen) in models of Parkinson\u2019s disease. Int. J. Mol. Sci. 17, 108. 10.3390/ijms17010108", "ArticleIdList": ["10.3390/ijms17010108", "PMC4730349", "26784178"]}, {"Citation": "Clarke C. E., Patel S., Ives N., Rick C. E., Dowling F., Woolley R., et al. (2016). Physiotherapy and occupational therapy vs no therapy in mild to moderate Parkinson disease: A randomized clinical trial. JAMA Neurol. 73, 291\u2013299. 10.1001/jamaneurol.2015.4452", "ArticleIdList": ["10.1001/jamaneurol.2015.4452", "26785394"]}, {"Citation": "Collerton D., Burn D., McKeith I., O\u2019Brien J. J. D., disorders G. C. (2003). Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia. Dement. Geriatr. Cogn. Disord. 16, 229\u2013237. 10.1159/000072807", "ArticleIdList": ["10.1159/000072807", "14512718"]}, {"Citation": "Comella C. L., Morrissey M., Janko K. J. N. (2005). Nocturnal activity with nighttime pergolide in Parkinson disease: A controlled study using actigraphy. Neurology 64, 1450\u20131451. 10.1212/01.WNL.0000158652.74601.48", "ArticleIdList": ["10.1212/01.WNL.0000158652.74601.48", "15851743"]}, {"Citation": "Corona J. C. J. B. (2018). Natural compounds for the management of Parkinson\u2019s disease and attention-deficit/hyperactivity disorder. Biomed. Res. Int. 2018. 10.1155/2018/4067597", "ArticleIdList": ["10.1155/2018/4067597", "PMC6282143", "30596091"]}, {"Citation": "Corr\u00eaa S. A., Eales K. L. J. J. o. s. t. (2012). The role of p38 MAPK and its substrates in neuronal plasticity and neurodegenerative disease. J. Signal Transduct. 2012.", "ArticleIdList": ["PMC3389708", "22792454"]}, {"Citation": "da Fonseca A. C. C., Matias D., Garcia C., Amaral R., Geraldo L. H., Freitas C., et al. (2014). The impact of microglial activation on blood-brain barrier in brain diseases. Front. Cell. Neurosci. 8, 362. 10.3389/fncel.2014.00362", "ArticleIdList": ["10.3389/fncel.2014.00362", "PMC4217497", "25404894"]}, {"Citation": "DeFeudis F., Drieu K. J. C. (2000). Ginkgo biloba extract (EGb 761) and CNS functions basic studies and clinical applications. Curr. Drug Targets 1, 25\u201358. 10.2174/1389450003349380", "ArticleIdList": ["10.2174/1389450003349380", "11475535"]}, {"Citation": "Dexter D. T., Jenner P., Schapira A. H., Marsden C. D., Society C. N. (1992). Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group. Ann. Neurol. 32, S94\u2013S100. 10.1002/ana.410320716", "ArticleIdList": ["10.1002/ana.410320716", "1510387"]}, {"Citation": "Dhawan K., Dhawan S., Sharma A. J. J. (2004). Passiflora: A review update. J. Ethnopharmacol. 94, 1\u201323. 10.1016/j.jep.2004.02.023", "ArticleIdList": ["10.1016/j.jep.2004.02.023", "15261959"]}, {"Citation": "Diaz N. L., Waters C. H. J. (2009). Current strategies in the treatment of Parkinson\u2019s disease and a personalized approach to management. Expert Rev. Neurother. 9, 1781\u20131789. 10.1586/ern.09.117", "ArticleIdList": ["10.1586/ern.09.117", "19951137"]}, {"Citation": "Doke R. R., Pansare P. A., Sainani S. R., Bhalchim V. M., Rode K. R., Desai S. R. (2019). Natural products: An emerging tool in Parkinson\u2019s disease."}, {"Citation": "Dorsey E. a., Constantinescu R., Thompson J., Biglan K., Holloway R., Kieburtz K., et al. (2007). Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68, 384\u2013386. 10.1212/01.wnl.0000247740.47667.03", "ArticleIdList": ["10.1212/01.wnl.0000247740.47667.03", "17082464"]}, {"Citation": "Duka T., Duka V., Joyce J. N., Sidhu A. J. T. F. J., \"Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models., \" vol. 23, pp. 2820\u20132830. 10.1096/fj.08-120410 2009.", "ArticleIdList": ["10.1096/fj.08-120410", "PMC2796901", "19369384"]}, {"Citation": "Eisensehr I., Linke R., Tatsch K., Kharraz B., Gildehaus J. F., Wetter C. T., et al. (2003). Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls. Sleep 26, 507\u2013512. 10.1093/sleep/26.5.507", "ArticleIdList": ["10.1093/sleep/26.5.507", "12938802"]}, {"Citation": "Elbaz A., Bower J. H., Maraganore D. M., McDonnell S. K., Peterson B. J., Ahlskog J. E., et al. (2002). Risk tables for parkinsonism and Parkinson's disease. J. Clin. Epidemiol. 55, 25\u201331. 10.1016/s0895-4356(01)00425-5", "ArticleIdList": ["10.1016/s0895-4356(01)00425-5", "11781119"]}, {"Citation": "Eldeeb M. A., Thomas R. A., Ragheb M. A., Fallahi A., Fon E. A. (2022). Mitochondrial quality control in health and in Parkinson's disease. Physiological Reviews.", "ArticleIdList": ["35466694"]}, {"Citation": "Empadinhas N., da Costa M. S. J. E. M. (2011). Diversity, biological roles and biosynthetic pathways for sugar\u2010glycerate containing compatible solutes in bacteria and archaea. Environ. Microbiol. 13, 2056\u20132077. 10.1111/j.1462-2920.2010.02390.x", "ArticleIdList": ["10.1111/j.1462-2920.2010.02390.x", "21176052"]}, {"Citation": "Essa M. M., Subash S., Dhanalakshmi C., Manivasagam T., Al-Adawi S., Guillemin G. J., et al. (2015). Dietary supplementation of walnut partially reverses 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine induced neurodegeneration in a mouse model of Parkinson\u2019s disease. Neurochem. Res. 40, 1283\u20131293. 10.1007/s11064-015-1593-2", "ArticleIdList": ["10.1007/s11064-015-1593-2", "25944473"]}, {"Citation": "Factor S. A., McAlarney T., Sanchez\u2010Ramos J. R., Weiner W. J. (1990). Sleep disorders and sleep effect in Parkinson's disease. Mov. Disord. 5, 280\u2013285. 10.1002/mds.870050404", "ArticleIdList": ["10.1002/mds.870050404", "2259351"]}, {"Citation": "Faria C., Jorge C. D., Borges N., Tenreiro S., Outeiro T. F., Santos H. J. B. B. B. A.-G. S. (2013). Inhibition of formation of \u03b1-synuclein inclusions by mannosylglycerate in a yeast model of Parkinson's disease. Biochim. Biophys. Acta 1830, 4065\u20134072. 10.1016/j.bbagen.2013.04.015", "ArticleIdList": ["10.1016/j.bbagen.2013.04.015", "23608058"]}, {"Citation": "Fei C., Shenggang S. J. J. H. U. S., E-tang T. (2003). Experimental study on inhibition of neuronal toxical effect of levodopa by ginkgo biloba extract on Parkinson disease in rats. Univ. Sci. Technol. Med. Sci. 23, 151\u2013153. 10.1007/BF02859941", "ArticleIdList": ["10.1007/BF02859941", "12973934"]}, {"Citation": "Feigin V. L., Roth G. A., Naghavi M., Parmar P., Krishnamurthi R., Chugh S., et al. (2016). Global burden of stroke and risk factors in 188 countries, during 1990\u20132013: A systematic analysis for the global burden of disease study 2013. Lancet. Neurol. 15, 913\u2013924. 10.1016/S1474-4422(16)30073-4", "ArticleIdList": ["10.1016/S1474-4422(16)30073-4", "27291521"]}, {"Citation": "Ferini-Strambi L., Franceschi M., Pinto P., Zucconi M., Smirne S. J. G. (1992). Respiration and heart rate variability during sleep in untreated Parkinson patients. Gerontology 38, 92\u201398. 10.1159/000213312", "ArticleIdList": ["10.1159/000213312", "1612468"]}, {"Citation": "Fr\u00e9mont L. J. (2000). Biological effects of resveratrol. Life Sci. 66, 663\u2013673. 10.1016/s0024-3205(99)00410-5", "ArticleIdList": ["10.1016/s0024-3205(99)00410-5", "10680575"]}, {"Citation": "Friedmann T., Roblin R. J. S. (1972). Gene therapy for human genetic disease? Science 175, 949\u2013955. 10.1126/science.175.4025.949", "ArticleIdList": ["10.1126/science.175.4025.949", "5061866"]}, {"Citation": "Gagnon J.-F., B\u00e9dard M.-A., Fantini M., Petit D., Panisset M., Rompre S., et al. (2002). REM sleep behavior disorder and REM sleep without atonia in Parkinson\u2019s disease. Neurology 59, 585\u2013589. 10.1212/wnl.59.4.585", "ArticleIdList": ["10.1212/wnl.59.4.585", "12196654"]}, {"Citation": "Galasso C., Corinaldesi C., Sansone C. J. A. (2017). Carotenoids from marine organisms: Biological functions and industrial applications. Antioxidants 6, 96. 10.3390/antiox6040096", "ArticleIdList": ["10.3390/antiox6040096", "PMC5745506", "29168774"]}, {"Citation": "Gammone M. A., Riccioni G., D'Orazio N. J. M. D. (2015). Marine carotenoids against oxidative stress: Effects on human health. Mar. Drugs 13, 6226\u20136246. 10.3390/md13106226", "ArticleIdList": ["10.3390/md13106226", "PMC4626686", "26437420"]}, {"Citation": "Gattellaro G., Minati L., Grisoli M., Mariani C., Carella F., Osio M., et al. (2009). White matter involvement in idiopathic Parkinson disease: A diffusion tensor imaging study. AJNR. Am. J. Neuroradiol. 30, 1222\u20131226. 10.3174/ajnr.A1556", "ArticleIdList": ["10.3174/ajnr.A1556", "PMC7051338", "19342541"]}, {"Citation": "Gjerstad M., Aarsland D., Larsen J. J. N. (2002). Development of daytime somnolence over time in Parkinson\u2019s disease. Neurology 58, 1544\u20131546. 10.1212/wnl.58.10.1544", "ArticleIdList": ["10.1212/wnl.58.10.1544", "12034797"]}, {"Citation": "Global R. (2018). National incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: A systematic analysis for the global burden of disease study 2017. Lancet 392, 1789\u20131858.", "ArticleIdList": ["PMC6227754", "30496104"]}, {"Citation": "Golpich M., Amini E., Hemmati F., Ibrahim N. M., Rahmani B., Mohamed Z., et al. (2015). Glycogen synthase kinase-3 beta (GSK-3\u03b2) signaling: Implications for Parkinson's disease. Pharmacol. Res. 97, 16\u201326. 10.1016/j.phrs.2015.03.010", "ArticleIdList": ["10.1016/j.phrs.2015.03.010", "25829335"]}, {"Citation": "Grealish S., Diguet E., Kirkeby A., Mattsson B., Heuer A., Bramoulle Y., et al. (2014). Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson\u2019s disease. Cell Stem Cell 15, 653\u2013665. 10.1016/j.stem.2014.09.017", "ArticleIdList": ["10.1016/j.stem.2014.09.017", "PMC4232736", "25517469"]}, {"Citation": "Grimmig B., Daly L., Hudson C., Nash K., Bickford P. J. F. F. H. (2017). Astaxanthin attenuates neurotoxicity in a mouse model of Parkinson\u2019s disease. Funct. Foods Health Dis. 7, 562\u2013576. 10.31989/ffhd.v7i8.352", "ArticleIdList": ["10.31989/ffhd.v7i8.352"]}, {"Citation": "Grimmig B., Kim S.-H., Nash K., Bickford P. C., Douglas Shytle R. J. G. (2017). Neuroprotective mechanisms of astaxanthin: A potential therapeutic role in preserving cognitive function in age and neurodegeneration. Geroscience 39, 19\u201332. 10.1007/s11357-017-9958-x", "ArticleIdList": ["10.1007/s11357-017-9958-x", "PMC5352583", "28299644"]}, {"Citation": "Gu P. S., Moon M., Choi J. G., Oh M. S. J. T. J. (2017). Mulberry fruit ameliorates Parkinson's-disease-related pathology by reducing \u03b1-synuclein and ubiquitin levels in a 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine/probenecid model. J. Nutr. Biochem. 39, 15\u201321. 10.1016/j.jnutbio.2016.08.014", "ArticleIdList": ["10.1016/j.jnutbio.2016.08.014", "27741433"]}, {"Citation": "Gu Q., Huang P., Xuan M., Xu X., Li D., Sun J., et al. (2014). Greater loss of white matter integrity in postural instability and gait difficulty subtype of Parkinson's disease. Can. J. Neurol. Sci. 41, 763\u2013768. 10.1017/cjn.2014.34", "ArticleIdList": ["10.1017/cjn.2014.34", "25377626"]}, {"Citation": "Gualtieri C. T. J. J. I. M. (2004). Dementia screening in light of the diversity of the condition. J. Insur. Med. 36, 298\u2013309.", "ArticleIdList": ["15683208"]}, {"Citation": "Gupta S. C., Patchva S., Koh W., Aggarwal B. B. J. C. (2012). Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin. Exp. Pharmacol. Physiol. 39, 283\u2013299. 10.1111/j.1440-1681.2011.05648.x", "ArticleIdList": ["10.1111/j.1440-1681.2011.05648.x", "PMC3288651", "22118895"]}, {"Citation": "Hacker C. D., Perlmutter J. S., Criswell S. R., Ances B. M., Snyder A. Z. J. B. (2012). Resting state functional connectivity of the striatum in Parkinson\u2019s disease. Brain 135, 3699\u20133711. 10.1093/brain/aws281", "ArticleIdList": ["10.1093/brain/aws281", "PMC3525055", "23195207"]}, {"Citation": "Happe S., Schr\u00f6dl B., Faltl M., M\u00fcller C., Auff E., Zeitlhofer J. J. A. N. S. (2001). Sleep disorders and depression in patients with Parkinson's disease: Results of a study with the sleep disorders questionnaire (SDQ) and the zung depression scale (ZDS). Acta Neurol. Scand. 104, 275\u2013280. 10.1034/j.1600-0404.2001.00024.x", "ArticleIdList": ["10.1034/j.1600-0404.2001.00024.x", "11696021"]}, {"Citation": "Hara H., Onodera H., Yoshidomi M., Matsuda Y., Kogure K. J. J. o. C. B. F. (1990). Staurosporine, a novel protein kinase C inhibitor, prevents postischemic neuronal damage in the gerbil and rat. J. Cereb. Blood Flow. Metab. 10, 646\u2013653. 10.1038/jcbfm.1990.117", "ArticleIdList": ["10.1038/jcbfm.1990.117", "2384538"]}, {"Citation": "Hauser R. A., Gauger L., Anderson W. M., Zesiewicz T. A. J. (2000). Pramipexole-induced somnolence and episodes of daytime sleep. Mov. Disord. 15, 658\u2013663. 10.1002/1531-8257(200007)15:4<658::aid-mds1009>3.0.co;2-n", "ArticleIdList": ["10.1002/1531-8257(200007)15:4<658::aid-mds1009>3.0.co;2-n", "10928575"]}, {"Citation": "Hindle J. V. J. A., Ageing (2010). Ageing, neurodegeneration and Parkinson's disease. Age Ageing 39, 156\u2013161. 10.1093/ageing/afp223", "ArticleIdList": ["10.1093/ageing/afp223", "20051606"]}, {"Citation": "Hobson D. E., Lang A. E., Martin W. W., Razmy A., Rivest J., Fleming J. J. J., \"Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: A survey by the Canadian movement disorders group, \" vol. 287, pp. 455\u2013463. 10.1001/jama.287.4.455 2002.", "ArticleIdList": ["10.1001/jama.287.4.455", "11798367"]}, {"Citation": "Hosamani R., Krishna G., Muralidhara G. (2016). Standardized Bacopa monnieri extract ameliorates acute paraquat-induced oxidative stress, and neurotoxicity in prepubertal mice brain. Nutr. Neurosci. 19, 434\u2013446. 10.1179/1476830514Y.0000000149", "ArticleIdList": ["10.1179/1476830514Y.0000000149", "25153704"]}, {"Citation": "Hosamani R. (2009). Neuroprotective efficacy of Bacopa monnieri against rotenone induced oxidative stress and neurotoxicity in Drosophila melanogaster . Neurotoxicology 30, 977\u2013985. 10.1016/j.neuro.2009.08.012", "ArticleIdList": ["10.1016/j.neuro.2009.08.012", "19744517"]}, {"Citation": "Hunot S., Vila M., Teismann P., Davis R. J., Hirsch E. C., Przedborski S., et al. (2004). JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 101, 665\u2013670. 10.1073/pnas.0307453101", "ArticleIdList": ["10.1073/pnas.0307453101", "PMC327205", "14704277"]}, {"Citation": "Ikram S., Parra-Payano V. D., Kammaripalle T. K. C., Datta A., Kaur M., Bhushan T., et al. (2021). Progressive supranuclear palsy: A case report and literature review. Arch. Clin. Med. Case Rep. 5, 838\u2013845. 10.26502/acmcr.96550428", "ArticleIdList": ["10.26502/acmcr.96550428"]}, {"Citation": "Im H.-I., Joo W. S., Nam E., Lee E.-S., Hwang Y.-j., Kim Y. S. J. J. (2005). Baicalein prevents 6-hydroxydopamine-induced dopaminergic dysfunction and lipid peroxidation in mice. J. Pharmacol. Sci. 98, 185\u2013189. 10.1254/jphs.sc0050014", "ArticleIdList": ["10.1254/jphs.sc0050014", "15942123"]}, {"Citation": "Ingale S. P., Kasture S. B. J. A. S. (2017). Protective effect of standardized extract of Passiflora incarnata flower in Parkinson\u2019s and Alzheimer\u2019s disease. Anc. Sci. Life 36, 200. 10.4103/asl.ASL_231_16", "ArticleIdList": ["10.4103/asl.ASL_231_16", "PMC5726187", "29269972"]}, {"Citation": "Iranzo A., Santamaria J., Rye D., Valldeoriola F., Mart\u00ed M., Mu\u00f1oz E., et al. (2005). Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD. Neurology 65, 247\u2013252. 10.1212/01.wnl.0000168864.97813.e0", "ArticleIdList": ["10.1212/01.wnl.0000168864.97813.e0", "16043794"]}, {"Citation": "Isozaki E., Naito A., Horiguchi S., Kawamura R., Hayashida T., Tanabe H. J. J. N., et al. (1996). Early diagnosis and stage classification of vocal cord abductor paralysis in patients with multiple system atrophy. J. Neurol. Neurosurg. Psychiatry 60, 399\u2013402. 10.1136/jnnp.60.4.399", "ArticleIdList": ["10.1136/jnnp.60.4.399", "PMC1073892", "8774404"]}, {"Citation": "Ito H., Kusaka H., Matsumoto S., Imai T. J. N. (1996). Striatal efferent involvement and its correlation to levodopa efficacy in patients with multiple system atrophy. Neurology 47, 1291\u20131299. 10.1212/wnl.47.5.1291", "ArticleIdList": ["10.1212/wnl.47.5.1291", "8909445"]}, {"Citation": "Jansen E., Meerwaldtt J. J. A. (1990). Madopar HBS in nocturnal symptoms of Parkinson's disease. Adv. Neurol. 53, 527\u2013531.", "ArticleIdList": ["2239493"]}, {"Citation": "Jenner P. J. P. (2003). The contribution of the MPTP-treated primate model to the development of new treatment strategies for Parkinson's disease. Park. Relat. Disord. 9, 131\u2013137. 10.1016/s1353-8020(02)00115-3", "ArticleIdList": ["10.1016/s1353-8020(02)00115-3", "12573867"]}, {"Citation": "Jenner P., Rupniak N. M., Rose S., Kelly E., Kilpatrick G., Lees A., et al. (1984). 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced parkinsonism in the common marmoset. Neurosci. Lett. 50, 85\u201390. 10.1016/0304-3940(84)90467-1", "ArticleIdList": ["10.1016/0304-3940(84)90467-1", "6436758"]}, {"Citation": "Jia H., Jiang Y., Ruan Y., Zhang Y., Ma X., Zhang J., et al. (2004). Tenuigenin treatment decreases secretion of the Alzheimer\u2019s disease amyloid \u03b2-protein in cultured cells. Neurosci. Lett. 367, 123\u2013128. 10.1016/j.neulet.2004.05.093", "ArticleIdList": ["10.1016/j.neulet.2004.05.093", "15308312"]}, {"Citation": "Jiang W., Wang Z., Jiang Y., Lu M., Li X. J. P. (2015). Ginsenoside Rg1 ameliorates motor function in an animal model of Parkinson's disease. Pharmacology 96, 25\u201331. 10.1159/000431100", "ArticleIdList": ["10.1159/000431100", "26065578"]}, {"Citation": "Jin F., Wu Q., Lu Y.-F., Gong Q.-H., Shi J.-S. J. E. (2008). Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats. Eur. J. Pharmacol. 600, 78\u201382. 10.1016/j.ejphar.2008.10.005", "ArticleIdList": ["10.1016/j.ejphar.2008.10.005", "18940189"]}, {"Citation": "Jing X., Wei X., Ren M., Wang L., Zhang X., Lou H. J. N. r. (2016). Neuroprotective effects of tanshinone I against 6-OHDA-induced oxidative stress in cellular and mouse model of Parkinson\u2019s disease through upregulating Nrf2. Neurochem. Res. 41, 779\u2013786. 10.1007/s11064-015-1751-6", "ArticleIdList": ["10.1007/s11064-015-1751-6", "26537816"]}, {"Citation": "Juncos J., Fabbrini G., Mouradian M., Chase T. J. A. (1987). Controlled release levodopa-carbidopa (CR-5) in the management of parkinsonian motor fluctuations. Arch. Neurol. 44, 1010\u20131012. 10.1001/archneur.1987.00520220016008", "ArticleIdList": ["10.1001/archneur.1987.00520220016008", "3632371"]}, {"Citation": "Kajimura Y., Aoki T., Kuramochi K., Kobayashi S., Sugawara F., Watanabe N., et al. (2008). Neoechinulin A protects PC12 cells against MPP+-induced cytotoxicity. J. Antibiot. 61, 330\u2013333. 10.1038/ja.2008.48", "ArticleIdList": ["10.1038/ja.2008.48", "18654001"]}, {"Citation": "Kales A., Ansel R. D., Markham C. H., Scharf M. B., Tan T.-L. J. C. P. (1971). Sleep in patients with Parkinson's disease and normal subiects prior to and following levodopa administration. Clin. Pharmacol. Ther. 12, 397\u2013406. 10.1002/cpt1971122part2397", "ArticleIdList": ["10.1002/cpt1971122part2397", "4325251"]}, {"Citation": "Karakida F., Ikeya Y., Tsunakawa M., Yamaguchi T., Ikarashi Y., Takeda S., et al. (2007). Cerebral protective and cognition-improving effects of sinapic acid in rodents. Biol. Pharm. Bull. 30, 514\u2013519. 10.1248/bpb.30.514", "ArticleIdList": ["10.1248/bpb.30.514", "17329848"]}, {"Citation": "Karaman M. W., Herrgard S., Treiber D. K., Gallant P., Atteridge C. E., Campbell B. T., et al. (2008). A quantitative analysis of kinase inhibitor selectivity. Nat. Biotechnol. 26, 127\u2013132. 10.1038/nbt1358", "ArticleIdList": ["10.1038/nbt1358", "18183025"]}, {"Citation": "Kiasalari Z., Baluchnejadmojarad T., Roghani M. J. C., Neurobiology M. (2016). Hypericum perforatum hydroalcoholic extract mitigates motor dysfunction and is neuroprotective in intrastriatal 6-Hydroxydopamine rat model of Parkinson\u2019s disease. Cell. Mol. Neurobiol. 36, 521\u2013530. 10.1007/s10571-015-0230-6", "ArticleIdList": ["10.1007/s10571-015-0230-6", "26119304"]}, {"Citation": "Kim D. S., Park S.-Y., Kim J.-Y. J. N. (2001). Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from betaA(1-42) insult. Neurosci. Lett. 303, 57\u201361. 10.1016/s0304-3940(01)01677-9", "ArticleIdList": ["10.1016/s0304-3940(01)01677-9", "11297823"]}, {"Citation": "Kimoto K., Aoki T., Shibata Y., Kamisuki S., Sugawara F., Kuramochi K., et al. (2007). Structure-activity relationships of neoechinulin A analogues with cytoprotection against peroxynitrite-induced PC12 cell death. J. Antibiot. 60, 614\u2013621. 10.1038/ja.2007.79", "ArticleIdList": ["10.1038/ja.2007.79", "17965477"]}, {"Citation": "Kirkeby A., Grealish S., Wolf D. A., Nelander J., Wood J., Lundblad M., et al. (2012). Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. Cell Rep. 1, 703\u2013714. 10.1016/j.celrep.2012.04.009", "ArticleIdList": ["10.1016/j.celrep.2012.04.009", "22813745"]}, {"Citation": "Kiyama R. J. E. J. (2017). Estrogenic terpenes and terpenoids: Pathways, functions and applications. Eur. J. Pharmacol. 815, 405\u2013415. 10.1016/j.ejphar.2017.09.049", "ArticleIdList": ["10.1016/j.ejphar.2017.09.049", "28970013"]}, {"Citation": "Klein C., Westenberger A. (2012). Genetics of Parkinson\u2019s disease. Cold Spring Harb. Perspect. Med. 2, a008888. 10.1101/cshperspect.a008888", "ArticleIdList": ["10.1101/cshperspect.a008888", "PMC3253033", "22315721"]}, {"Citation": "Koppula S., Kumar H., More S. V., Kim B. W., Kim I. S., Choi D.-K. J. I. (2012). Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson\u2019s disease. Int. J. Mol. Sci. 13, 10608\u201310629. 10.3390/ijms130810608", "ArticleIdList": ["10.3390/ijms130810608", "PMC3431881", "22949883"]}, {"Citation": "Kosaraju J., Chinni S., Roy P. D., Kannan E., Antony A. S., Kumar M. S. (2014). Neuroprotective effect of Tinospora cordifolia ethanol extract on 6-hydroxy dopamine induced Parkinsonism. Indian J. Pharmacol. 46, 176\u2013180. 10.4103/0253-7613.129312", "ArticleIdList": ["10.4103/0253-7613.129312", "PMC3987186", "24741189"]}, {"Citation": "Kowal S. L., Dall T. M., Chakrabarti R., Storm M. V., Jain A. (2013). The current and projected economic burden of Parkinson's disease in the United States. Mov. Disord. 28, 311\u2013318. 10.1002/mds.25292", "ArticleIdList": ["10.1002/mds.25292", "23436720"]}, {"Citation": "Kriks S., Shim J.-W., Piao J., Ganat Y. M., Wakeman D. R., Xie Z., et al. (2011). Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson\u2019s disease. Nature 480, 547\u2013551. 10.1038/nature10648", "ArticleIdList": ["10.1038/nature10648", "PMC3245796", "22056989"]}, {"Citation": "Kuan C.-Y., Burke R. E. J. C. D. T.-C., Disorders N. (2005). Targeting the JNK signaling pathway for stroke and Parkinson's diseases therapy. Curr. Drug Targets. CNS Neurol. Disord. 4, 63\u201367. 10.2174/1568007053005145", "ArticleIdList": ["10.2174/1568007053005145", "15723614"]}, {"Citation": "Kubo S. i., Kitami T., Noda S., Shimura H., Uchiyama Y., Asakawa S., et al. (2001). Parkin is associated with cellular vesicles. J. Neurochem. 78, 42\u201354. 10.1046/j.1471-4159.2001.00364.x", "ArticleIdList": ["10.1046/j.1471-4159.2001.00364.x", "11432972"]}, {"Citation": "Kumar S., Behl T., Sehgal A., Chigurupati S., Singh S., Mani V., et al. (2022). Exploring the focal role of LRRK2 kinase in Parkinson\u2019s disease. Environmental Science and Pollution Research, 1\u201315.", "ArticleIdList": ["35147886"]}, {"Citation": "Kuribara H., Kishi E., Hattori N., Okada M., Maruyama Y. J. J., (2000). The anxiolytic effect of two oriental herbal drugs in Japan attributed to honokiol from magnolia bark. J. Pharm. Pharmacol. 52, 1425\u20131429. 10.1211/0022357001777432", "ArticleIdList": ["10.1211/0022357001777432", "11186252"]}, {"Citation": "Kurobane I., Iwahashi S., Fukuda A. J. D., research c., FukudA A. (1987). Cytostatic activity of naturally isolated isomers of secalonic acids and their chemically rearranged dimers. Drugs Exp. Clin. Res. 13, 339\u2013344.", "ArticleIdList": ["3652923"]}, {"Citation": "Lang A. E., Gill S., Patel N. K., Lozano A., Nutt J. G., Penn R., et al. (2006). Randomized controlled trial of intraputamenal glial cell line\u2013derived neurotrophic factor infusion in Parkinson disease. Ann. Neurol. 59, 459\u2013466. 10.1002/ana.20737", "ArticleIdList": ["10.1002/ana.20737", "16429411"]}, {"Citation": "Langston J. W., Ballard P., Tetrud J. W., Irwin I. J. S. (1983). Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979\u2013980. 10.1126/science.6823561", "ArticleIdList": ["10.1126/science.6823561", "6823561"]}, {"Citation": "Larsen J. P. J. (2003). Sleep disorders in Parkinson's disease. J. Park. Dis. 91, 329\u2013334. 10.3233/JPD-130301", "ArticleIdList": ["10.3233/JPD-130301", "12442690"]}, {"Citation": "Lees A. J., Blackburn N. A., Campbell V. L. J. C. (1988). The nighttime problems of Parkinson's disease. Clin. Neuropharmacol. 11, 512\u2013519. 10.1097/00002826-198812000-00004", "ArticleIdList": ["10.1097/00002826-198812000-00004", "3233589"]}, {"Citation": "Lees A. J. J. (2012). Impact commentaries. A modern perspective on the top 100 cited jnnp papers of all time: The relevance of the lewy body to the pathogenesis of idiopathic Parkinson's disease: Accuracy of clinical diagnosis of idiopathic Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 83, 954\u2013955. 10.1136/jnnp-2012-302969", "ArticleIdList": ["10.1136/jnnp-2012-302969", "22645254"]}, {"Citation": "Lei H., Ren R., Sun Y., Zhang K., Zhao X., Ablat N., et al. (2020). Neuroprotective effects of safflower flavonoid extract in 6-hydroxydopamine-induced model of Parkinson\u2019s disease may be related to its anti-inflammatory action. Molecules 25, 5206. 10.3390/molecules25215206", "ArticleIdList": ["10.3390/molecules25215206", "PMC7664856", "33182332"]}, {"Citation": "Lesser R. P., Fahn S., Snider S. R., Cote L. J., Isgreen W. P., Barrett R. E. J. N. (1979). Analysis of the clinical problems in parkinsonism and the complications of long\u2010term levodopa therapy. Neurology 29, 1253\u20131260. 10.1212/wnl.29.9_part_1.1253", "ArticleIdList": ["10.1212/wnl.29.9_part_1.1253", "573405"]}, {"Citation": "Li D., Wilkins K., McCollum A. M., Osadebe L., Kabamba J., Nguete B., et al. (2017). Evaluation of the GeneXpert for human monkeypox diagnosis. Am. J. Trop. Med. Hyg. 96, 405\u2013410. 10.4269/ajtmh.16-0567", "ArticleIdList": ["10.4269/ajtmh.16-0567", "PMC5303045", "27994107"]}, {"Citation": "Li J., Long X., Hu J., Bi J., Zhou T., Guo X., et al. (2019). Multiple pathways for natural product treatment of Parkinson's disease: A mini review. Phytomedicine 60, 152954. 10.1016/j.phymed.2019.152954", "ArticleIdList": ["10.1016/j.phymed.2019.152954", "31130327"]}, {"Citation": "Li X.-x., He G.-r., Mu X., Xu B., Tian S., Yu X., et al. (2012). Protective effects of baicalein against rotenone-induced neurotoxicity in PC12 cells and isolated rat brain mitochondria. Eur. J. Pharmacol. 674, 227\u2013233. 10.1016/j.ejphar.2011.09.181", "ArticleIdList": ["10.1016/j.ejphar.2011.09.181", "21996316"]}, {"Citation": "Li Y.-Y., Lu J.-H., Li Q., Zhao Y.-Y., Pu X.-P. J. E. (2008). Pedicularioside A from Buddleia lindleyana inhibits cell death induced by 1-methyl-4-phenylpyridinium ions (MPP+) in primary cultures of rat mesencephalic neurons. Eur. J. Pharmacol. 579, 134\u2013140. 10.1016/j.ejphar.2007.10.052", "ArticleIdList": ["10.1016/j.ejphar.2007.10.052", "18035349"]}, {"Citation": "Li Y., Li X., Kang J. S., Choi H. D., Son B. W. J. T. J. A. (2004). New radical scavenging and ultraviolet-A protecting prenylated dioxopiperazine alkaloid related to isoechinulin A from a marine isolate of the fungus Aspergillus. J. Antibiot. 57, 337\u2013340. 10.7164/antibiotics.57.337", "ArticleIdList": ["10.7164/antibiotics.57.337", "15303494"]}, {"Citation": "Lin J., Yu J., Zhao J., Zhang K., Zheng J., Wang J., et al. (2017). Fucoxanthin, a marine carotenoid, attenuates \u03b2-amyloid oligomer-induced neurotoxicity possibly via regulating the PI3K/akt and the ERK pathways in SH-SY5Y cells. Oxid. Med. Cell. Longev. 2017, 6792543. 10.1155/2017/6792543", "ArticleIdList": ["10.1155/2017/6792543", "PMC5591933", "28928905"]}, {"Citation": "Lindvall O., Barker R. A., Br\u00fcstle O., Isacson O., Svendsen C. N. J. (2012). Clinical translation of stem cells in neurodegenerative disorders. Cell Stem Cell 10, 151\u2013155. 10.1016/j.stem.2012.01.009", "ArticleIdList": ["10.1016/j.stem.2012.01.009", "PMC3982832", "22305565"]}, {"Citation": "Lindvall O. J. (2016). Clinical translation of stem cell transplantation in Parkinson's disease. J. Intern. Med. 279, 30\u201340. 10.1111/joim.12415", "ArticleIdList": ["10.1111/joim.12415", "26332959"]}, {"Citation": "Litvan I., Agid Y., Calne D., Campbell G., Dubois B., Duvoisin R., et al. (1996). Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP international workshop. Neurology 47, 1\u20139. 10.1212/wnl.47.1.1", "ArticleIdList": ["10.1212/wnl.47.1.1", "8710059"]}, {"Citation": "Litvan I., Agid Y., Jankovic J., Goetz C., Brandel J., Lai E., et al. (1996). Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology 46, 922\u2013930. 10.1212/wnl.46.4.922", "ArticleIdList": ["10.1212/wnl.46.4.922", "8780065"]}, {"Citation": "Litvan I., Bhatia K. P., Burn D. J., Goetz C. G., Lang A. E., McKeith I., et al. (2003). Movement disorders society scientific issues committee report: SIC task force appraisal of clinical diagnostic criteria for parkinsonian disorders. Mov. Disord. 18, 467\u2013486. 10.1002/mds.10459", "ArticleIdList": ["10.1002/mds.10459", "12722160"]}, {"Citation": "Litvan I., Booth V., Wenning G., Bartko J., Goetz C., McKee A., et al. (1998). Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy. J. Neural Transm. 105, 217\u2013227. 10.1007/s007020050050", "ArticleIdList": ["10.1007/s007020050050", "9660099"]}, {"Citation": "Litvan I., Goetz C. G., Jankovic J., Wenning G. K., Booth V., Bartko J. J., et al. (1997). What is the accuracy of the clinical diagnosis of multiple system atrophy? Arch. Neurol. 54, 937\u2013944. 10.1001/archneur.1997.00550200007003", "ArticleIdList": ["10.1001/archneur.1997.00550200007003", "9267967"]}, {"Citation": "Liu J., Dumontet V., Simonin A.-L., Iorga B. I., Guerineau V., Litaudon M., et al. (2011). Benzofurans from Styrax agrestis as acetylcholinesterase inhibitors: Structure\u2013activity relationships and molecular modeling studies. J. Nat. Prod. 74, 2081\u20132088. 10.1021/np200308j", "ArticleIdList": ["10.1021/np200308j", "21939219"]}, {"Citation": "Liu Y., Gao J., Peng M., Meng H., Ma H., Cai P., et al. (2018). A review on central nervous system effects of gastrodin. Front. Pharmacol. 9, 24. 10.3389/fphar.2018.00024", "ArticleIdList": ["10.3389/fphar.2018.00024", "PMC5801292", "29456504"]}, {"Citation": "Lopez O. L., Hamilton R., Becker J., Wisniewski S., Kaufer D., DeKosky S. J. N. (2000). Severity of cognitive impairment and the clinical diagnosis of AD with Lewy bodies. Neurology 54, 1780\u20131787. 10.1212/wnl.54.9.1780", "ArticleIdList": ["10.1212/wnl.54.9.1780", "10802784"]}, {"Citation": "LopezReal A., Rey P., SotoOtero R., MendezAlvarez E., LabandeiraGarcia J. J. J., Lopez-ReAl A. (2005). Angiotensin\u2010converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6\u2010hydroxydopamine rat model of Parkinsonism. J. Neurosci. Res. 81, 865\u2013873. 10.1002/jnr.20598", "ArticleIdList": ["10.1002/jnr.20598", "16015598"]}, {"Citation": "Lu J. H., Ardah M. T., Durairajan S. S. K., Liu L. F., Xie L. X., Fong W. F. D., et al. (2011). Baicalein inhibits formation of \u03b1\u2010synuclein oligomers within living cells and prevents a\u03b2 peptide fibrillation and oligomerisation. Chembiochem 12, 615\u2013624. 10.1002/cbic.201000604", "ArticleIdList": ["10.1002/cbic.201000604", "21271629"]}, {"Citation": "Lu K.-T., Ko M.-C., Chen B.-Y., Huang J.-C., Hsieh C.-W., Lee M.-C., et al. (2008). Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging. J. Agric. Food Chem. 56, 6910\u20136913. 10.1021/jf8007212", "ArticleIdList": ["10.1021/jf8007212", "18616261"]}, {"Citation": "Luo C., Song W., Chen Q., Zheng Z., Chen K., Cao B., et al. (2014). Reduced functional connectivity in early-stage drug-naive Parkinson's disease: A resting-state fMRI study. Neurobiol. Aging 35, 431\u2013441. 10.1016/j.neurobiolaging.2013.08.018", "ArticleIdList": ["10.1016/j.neurobiolaging.2013.08.018", "24074808"]}, {"Citation": "Lv Y.-Q., Yuan L., Sun Y., Dou H.-W., Su J.-H., Hou Z.-P., et al. (2022). Long-term hyperglycemia aggravates \u03b1-synuclein aggregation and dopaminergic neuronal loss in a Parkinson\u2019s disease mouse model. Transl. Neurodegener. 11, 14\u201316. 10.1186/s40035-022-00288-z", "ArticleIdList": ["10.1186/s40035-022-00288-z", "PMC8900445", "35255986"]}, {"Citation": "Mann V., Cooper J., Daniel S., Srai K., Jenner P., Marsden C., et al. (1994). Complex I, iron, and ferritin in Parkinson's disease substantia nigra. Ann. Neurol. 36, 876\u2013881. 10.1002/ana.410360612", "ArticleIdList": ["10.1002/ana.410360612", "7998774"]}, {"Citation": "Maria B., Sophia S., Michalis M., Charalampos L., Andreas P., John M. E., et al. (2003). Sleep breathing disorders in patients with idiopathic Parkinson's disease. Respir. Med. 97, 1151\u20131157. 10.1016/s0954-6111(03)00188-4", "ArticleIdList": ["10.1016/s0954-6111(03)00188-4", "14561023"]}, {"Citation": "Maurer K., Ihl R., Dierks T., Fr\u00f6lich L. J. J. (1997). Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type. J. Psychiatr. Res. 31, 645\u2013655. 10.1016/s0022-3956(97)00022-8", "ArticleIdList": ["10.1016/s0022-3956(97)00022-8", "9447569"]}, {"Citation": "McGeer P. L., Itagaki S., Akiyama H., McGeer E., Society (1988). Rate of cell death in parkinsonism indicates active neuropathological process. Ann. Neurol. 24, 574\u2013576. 10.1002/ana.410240415", "ArticleIdList": ["10.1002/ana.410240415", "3239957"]}, {"Citation": "McKeith I. G., Galasko D., Kosaka K., Perry E., Dickson D. W., Hansen L., et al. (1996). Consensus guidelines for the clinical and pathologic diagnosis of dementia with lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 47, 1113\u20131124. 10.1212/wnl.47.5.1113", "ArticleIdList": ["10.1212/wnl.47.5.1113", "8909416"]}, {"Citation": "McNaught K. S. P., Belizaire R., Isacson O., Jenner P., Olanow C. W. J. E. (2003). Altered proteasomal function in sporadic Parkinson's disease. Exp. Neurol. 179, 38\u201346. 10.1006/exnr.2002.8050", "ArticleIdList": ["10.1006/exnr.2002.8050", "12504866"]}, {"Citation": "Meenakshi S., Umayaparvathi S., Arumugam M., Balasubramanian T. J. A. P. T. B. (2011). In vitro antioxidant properties and FTIR analysis of two seaweeds of Gulf of Mannar. Asian Pac. J. Trop. Biomed. 1, S66\u2013S70. 10.1016/S2221-1691(11)60126-3", "ArticleIdList": ["10.1016/S2221-1691(11)60126-3"]}, {"Citation": "Memarzia A., Saadat S., Behrouz S., Boskabady M. H. (2022). Curcuma longa and curcumin affect respiratory and allergic disorders, experimental and clinical evidence: A comprehensive and updated review. Biofactors 48, 521\u2013551. 10.1002/biof.1818", "ArticleIdList": ["10.1002/biof.1818", "34932258"]}, {"Citation": "Mercuri N. B., Bernardi G. J. (2005). The \u2018magic\u2019of L-dopa: Why is it the gold standard Parkinson's disease therapy? Trends Pharmacol. Sci. 26, 341\u2013344. 10.1016/j.tips.2005.05.002", "ArticleIdList": ["10.1016/j.tips.2005.05.002", "15936832"]}, {"Citation": "Mirahmadi M., Rezanejadbardaji H., Irfan-Maqsood M., Mokhtari M. J., Naderi-Meshkin H. (2016). Stem cell therapy for neurodegenerative diseases: Strategies for regeneration against degeneration. Cell Ther. Regen. Med. J. 1. 10.15562/ctrm.11", "ArticleIdList": ["10.15562/ctrm.11"]}, {"Citation": "Mitchell K. T., Ostrem J. L. J. N. C. (2020). Surgical treatment of Parkinson disease. Neurol. Clin. 38, 293\u2013307. 10.1016/j.ncl.2020.01.001", "ArticleIdList": ["10.1016/j.ncl.2020.01.001", "32279711"]}, {"Citation": "Molina-Jim\u00e9nez M. a. F., S\u00e1nchez-Reus M. a. I., Andres D., Cascales M. a., Benedi J. J. B. R. (2004). Neuroprotective effect of fraxetin and myricetin against rotenone-induced apoptosis in neuroblastoma cells. Brain Res. 1009, 9\u201316. 10.1016/j.brainres.2004.02.065", "ArticleIdList": ["10.1016/j.brainres.2004.02.065", "15120578"]}, {"Citation": "Monciardini P., Iorio M., Maffioli S., Sosio M., Donadio S. J. M. (2014). Discovering new bioactive molecules from microbial sources. Microb. Biotechnol. 7, 209\u2013220. 10.1111/1751-7915.12123", "ArticleIdList": ["10.1111/1751-7915.12123", "PMC3992017", "24661414"]}, {"Citation": "Moon A. (2007). Schapira and differentiation. Mitochondrial Dysfunct. Parkinson's Dis. 14, 1261.", "ArticleIdList": ["17464321"]}, {"Citation": "M\u00f6ssner R., Henneberg A., Schmitt A., Syagailo Y., Gr\u00e4ssle M., Hennig T., et al. (2001). Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease. Mol. Psychiatry 6, 350\u2013352. 10.1038/sj.mp.4000849", "ArticleIdList": ["10.1038/sj.mp.4000849", "11326308"]}, {"Citation": "Mouatt-Prigent A., Muriel M.-P., Gu W.-J., El Hachimi K., L\u00fccking C., Brice A., et al. (2004). Ultrastructural localization of parkin in the rat brainstem, thalamus and basal ganglia. J. Neural Transm. 111, 1209\u20131218. 10.1007/s00702-004-0144-9", "ArticleIdList": ["10.1007/s00702-004-0144-9", "15480834"]}, {"Citation": "Mu X., He G.-R., Yuan X., Li X.-X., Du G.-H. J. P. B., Behavior (2011). Baicalein protects the brain against neuron impairments induced by MPTP in C57BL/6 mice. Pharmacol. Biochem. Behav. 98, 286\u2013291. 10.1016/j.pbb.2011.01.011", "ArticleIdList": ["10.1016/j.pbb.2011.01.011", "21262257"]}, {"Citation": "Nagashayana N., Sankarankutty P., Nampoothiri M., Mohan P., Mohanakumar K. (2000). Association of L-DOPA with recovery following Ayurveda medication in Parkinson\u2019s disease. J. Neurol. Sci. 176, 124\u2013127. 10.1016/s0022-510x(00)00329-4", "ArticleIdList": ["10.1016/s0022-510x(00)00329-4", "10930594"]}, {"Citation": "Nakaso K., Ito S., Nakashima K. J. N. (2008). Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells. Neurosci. Lett. 432, 146\u2013150. 10.1016/j.neulet.2007.12.034", "ArticleIdList": ["10.1016/j.neulet.2007.12.034", "18201823"]}, {"Citation": "Nam S.-J., Kauffman C. A., Jensen P. R., Fenical W. J. T. (2011). Isolation and characterization of actinoramides A-C, highly modified peptides from a marine Streptomyces sp. Tetrahedron 67, 6707\u20136712. 10.1016/j.tet.2011.04.051", "ArticleIdList": ["10.1016/j.tet.2011.04.051", "PMC3156444", "21857753"]}, {"Citation": "Nicholatos J. W., Francisco A. B., Bender C. A., Yeh T., Lugay F. J., Salazar J. E., et al. (2018). Nicotine promotes neuron survival and partially protects from Parkinson\u2019s disease by suppressing SIRT6. Acta Neuropathol. Commun. 6, 1\u201318. 10.1186/s40478-018-0625-y", "ArticleIdList": ["10.1186/s40478-018-0625-y", "PMC6223043", "30409187"]}, {"Citation": "Nikapitiya C. J. A., (2012). Bioactive secondary metabolites from marine microbes for drug discovery. Adv. Food Nutr. Res. 65, 363\u2013387. 10.1016/B978-0-12-416003-3.00024-X", "ArticleIdList": ["10.1016/B978-0-12-416003-3.00024-X", "22361200"]}, {"Citation": "Noda K., Kitami T., Gai W. P., Chegini F., Jensen P. H., Fujimura T., et al. (2005). Phosphorylated IkappaBalpha is a component of Lewy body of Parkinson's disease. Biochem. Biophys. Res. Commun. 331, 309\u2013317. 10.1016/j.bbrc.2005.03.167", "ArticleIdList": ["10.1016/j.bbrc.2005.03.167", "15845394"]}, {"Citation": "Noyce A. J., Lees A. J., Schrag A.-E. J. J. N. (2016). The prediagnostic phase of Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 87, 871\u2013878. 10.1136/jnnp-2015-311890", "ArticleIdList": ["10.1136/jnnp-2015-311890", "PMC4975823", "26848171"]}, {"Citation": "Obeso J. A., Rodriguez-Oroz M. C., Goetz C. G., Marin C., Kordower J. H., Rodriguez M., et al. (2010). Missing pieces in the Parkinson's disease puzzle. Nat. Med. 16, 653\u2013661. 10.1038/nm.2165", "ArticleIdList": ["10.1038/nm.2165", "20495568"]}, {"Citation": "Odin P., Wolters E., Antonini A. J. N. S. (2008). Continuous dopaminergic stimulation achieved by duodenal levodopa infusion. Neurol. Sci. 29, 387\u2013388. 10.1007/s10072-008-1054-7", "ArticleIdList": ["10.1007/s10072-008-1054-7", "19381770"]}, {"Citation": "Ohlendorf B., Schulz D., Erhard A., Nagel K., Imhoff J. F. J. N. P. (2012). Geranylphenazinediol, an acetylcholinesterase inhibitor produced by a Streptomyces species. J. Nat. Prod. 75, 1400\u20131404. 10.1021/np2009626", "ArticleIdList": ["10.1021/np2009626", "22775474"]}, {"Citation": "Ojha R. P., Rastogi M., Devi B. P., Agrawal A., Dubey G. J. J. N. P. (2012). Neuroprotective effect of curcuminoids against inflammation-mediated dopaminergic neurodegeneration in the MPTP model of Parkinson\u2019s disease. J. Neuroimmune Pharmacol. 7, 609\u2013618. 10.1007/s11481-012-9363-2", "ArticleIdList": ["10.1007/s11481-012-9363-2", "22527634"]}, {"Citation": "Olanow C., Hauser R., Gauguster L., Malapira T., Koller W., Hubble J., et al. (1995). The effect of deprenyl and levodopa on the progression of Parkinson's disease. Ann. Neurol. 38, 771\u2013777. 10.1002/ana.410380512", "ArticleIdList": ["10.1002/ana.410380512", "7486869"]}, {"Citation": "Olanow C. W., Watts R. L., Koller W. C. J. N. (2001). An algorithm (decision tree) for the management of Parkinson's disease (2001): Treatment guidelines. Neurology 56, S1\u2013S88. 10.1212/wnl.56.suppl_5.s1", "ArticleIdList": ["10.1212/wnl.56.suppl_5.s1", "11402154"]}, {"Citation": "Pahwa R., Busenbark K., Huber S., Michalek D., Hubble J., Koller W. J. N. (1993). Clinical experience with controlled\u2010release carbidopa/levodopa in Parkinson's disease. Neurology 43, 677\u2013681. 10.1212/wnl.43.4.677", "ArticleIdList": ["10.1212/wnl.43.4.677", "8469321"]}, {"Citation": "Pahwa R., Lyons K. E. (2009). Levodopa-related wearing-off in Parkinson's disease: Identification and management. Curr. Med. Res. Opin. 25, 841\u2013849. 10.1185/03007990902779319", "ArticleIdList": ["10.1185/03007990902779319", "19228103"]}, {"Citation": "Paravati S., Rosani A., Warrington S. J. (2018). Physiology. catecholamines.", "ArticleIdList": ["29939538"]}, {"Citation": "Park S.-Y., Kim D. S. J. J. (2002). Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult: A drug discovery effort against alzheimer's disease. J. Nat. Prod. 65, 1227\u20131231. 10.1021/np010039x", "ArticleIdList": ["10.1021/np010039x", "12350137"]}, {"Citation": "Phani S., Loike J. D., Przedborski S. (2012). Neurodegeneration and inflammation in Parkinson's disease. Park. Relat. Disord. 18, S207\u2013S209. 10.1016/S1353-8020(11)70064-5", "ArticleIdList": ["10.1016/S1353-8020(11)70064-5", "22166436"]}, {"Citation": "Postuma R. B., Berg D., Stern M., Poewe W., Olanow C. W., Oertel W., et al. (2015). MDS clinical diagnostic criteria for Parkinson's disease. Mov. Disord. 30, 1591\u20131601. 10.1002/mds.26424", "ArticleIdList": ["10.1002/mds.26424", "26474316"]}, {"Citation": "Prodoehl J., Burciu R. G., Vaillancourt D. E. J., (2014). Resting state functional magnetic resonance imaging in Parkinson\u2019s disease. Curr. Neurol. Neurosci. Rep. 14, 448. 10.1007/s11910-014-0448-6", "ArticleIdList": ["10.1007/s11910-014-0448-6", "24744021"]}, {"Citation": "Quesada A., Lee B. Y., Micevych P. E. J. D. (2008). PI3 kinase/Akt activation mediates estrogen and IGF\u20101 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson's disease. Dev. Neurobiol. 68, 632\u2013644. 10.1002/dneu.20609", "ArticleIdList": ["10.1002/dneu.20609", "PMC2667142", "18278798"]}, {"Citation": "Rahman M., Islam F., Parvez A., Azad M. A., Ashraf G. M., Ullah M. F., et al. (2022). Citrus limon L.(lemon) seed extract shows neuro-modulatory activity in an in vivo thiopental-sodium sleep model by reducing the sleep onset and enhancing the sleep duration. J. Integr. Neurosci. 21, 042. 10.31083/j.jin2101042", "ArticleIdList": ["10.31083/j.jin2101042", "35164478"]}, {"Citation": "Rahman M. M., Ferdous K. S., Ahmed M. (2020). Emerging promise of nanoparticle-based treatment for Parkinson\u2019s disease. Biointerface Res. Appl. Chem. 10, 7135\u20137151."}, {"Citation": "Rahman M. M., Ferdous K. S., Ahmed M., Islam M. T., Khan M., Perveen A., et al. (2021). Hutchinson-gilford progeria syndrome: An overview of the molecular mechanism, pathophysiology and therapeutic approach. Curr. Gene Ther. 21, 216\u2013229. 10.2174/1566523221666210303100805", "ArticleIdList": ["10.2174/1566523221666210303100805", "33655857"]}, {"Citation": "Rahman M. M., Islam M. R., Islam M. T., Harun-Or-Rashid M., Islam M., Abdullah S., et al. (2022). Stem cell transplantation therapy and neurological disorders: Current status and future perspectives. Biology 11, 147. 10.3390/biology11010147", "ArticleIdList": ["10.3390/biology11010147", "PMC8772847", "35053145"]}, {"Citation": "Rahman M. M., Islam M. R., Shohag S., Ahasan M. T., Sarkar N., Khan H., et al. (2022). Microbiome in cancer: Role in carcinogenesis and impact in therapeutic strategies. Biomed. Pharmacother. 149, 112898.", "ArticleIdList": ["35381448"]}, {"Citation": "Rahman M. M., Rahaman M. S., Islam M. R., Rahman F., Mithi F. M., Alqahtani T., et al. (2021). Role of phenolic compounds in human disease: Current knowledge and future prospects. Molecules 27, 233. 10.3390/molecules27010233", "ArticleIdList": ["10.3390/molecules27010233", "PMC8746501", "35011465"]}, {"Citation": "Rahman M., Rahaman M., Islam M., Hossain M., Mannan Mithi F., Ahmed M., et al. (2021). Multifunctional therapeutic potential of phytocomplexes and natural extracts for antimicrobial properties. Antibiot. (Basel). 10, 1076. 10.3390/antibiotics10091076", "ArticleIdList": ["10.3390/antibiotics10091076", "PMC8468069", "34572660"]}, {"Citation": "Ramassamy C., Clostre F., Christen Y., Costentin J. J. J. (1990). Prevention by a Ginkgo biloba extract (GBE 761) of the dopaminergic neurotoxicity of MPTP. J. Pharm. Pharmacol. 42, 785\u2013789. 10.1111/j.2042-7158.1990.tb07021.x", "ArticleIdList": ["10.1111/j.2042-7158.1990.tb07021.x", "1982302"]}, {"Citation": "Ravikumar H., Muralidhara G. (2010). Prophylactic treatment with Bacopa monnieri leaf powder mitigates paraquat-induced oxidative perturbations and lethality in Drosophila melanogaster . Indian J. biochem. Biophys. 47, 75\u201382.", "ArticleIdList": ["20521619"]}, {"Citation": "Ren R., Shi C., Cao J., Sun Y., Zhao X., Guo Y., et al. (2016). Neuroprotective effects of a standardized flavonoid extract of safflower against neurotoxin-induced cellular and animal models of Parkinson\u2019s disease. Sci. Rep. 6, 1\u201313. 10.1038/srep22135", "ArticleIdList": ["10.1038/srep22135", "PMC4764910", "26906725"]}, {"Citation": "Rezaei M., Nasri S., Roughani M., Niknami Z., Ziai S. A. J. I. I. (2016). Peganum Harmala L. extract reduces oxidative stress and improves symptoms in 6-Hydroxydopamine-induced Parkinson\u2019s disease in rats. Iran. J. Pharm. Res. 15, 275\u2013281.", "ArticleIdList": ["PMC4986102", "27610168"]}, {"Citation": "Richardson J. R., Shalat S. L., Buckley B., Winnik B., O\u2019Suilleabhain P., Diaz-Arrastia R., et al. (2009). Elevated serum pesticide levels and risk of Parkinson disease. Arch. Neurol. 66, 870\u2013875. 10.1001/archneurol.2009.89", "ArticleIdList": ["10.1001/archneurol.2009.89", "PMC3383784", "19597089"]}, {"Citation": "Riley D., Lang A., Lewis A. e., Resch L., Ashby P., Hornykiewicz O., et al. (1990). Cortical-basal ganglionic degeneration. Neurology 40, 1203\u20131212. 10.1212/wnl.40.8.1203", "ArticleIdList": ["10.1212/wnl.40.8.1203", "2381527"]}, {"Citation": "Rocchi L., Carlson-Kuhta P., Chiari L., Burchiel K. J., Hogarth P., Horak F. B. J., \"Effects of deep brain stimulation in the subthalamic nucleus or globus pallidus internus on step initiation in Parkinson disease, \" vol. 117, pp. 1141\u20131149. 10.3171/2012.8.jns112006 2012.", "ArticleIdList": ["10.3171/2012.8.jns112006", "PMC3990225", "23039143"]}, {"Citation": "Roy N. S., Cleren C., Singh S. K., Yang L., Beal M. F., Goldman S. A. J. N. (2006). Functional engraftment of human ES cell\u2013derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat. Med. 12, 1259\u20131268. 10.1038/nm1495", "ArticleIdList": ["10.1038/nm1495", "17057709"]}, {"Citation": "Rudakewich M., Ba F., Benishin C. G. J. P. M. (2001). Neurotrophic and neuroprotective actions of ginsenosides Rb(1) and Rg(1). Planta Med. 67, 533\u2013537. 10.1055/s-2001-16488", "ArticleIdList": ["10.1055/s-2001-16488", "11509974"]}, {"Citation": "Rui W., Li S., Xiao H., Xiao M., Shi J. J. I. J. N. (2020). Baicalein attenuates neuroinflammation by inhibiting NLRP3/caspase-1/GSDMD pathway in MPTP-induced mice model of Parkinson\u2019s disease. Int. J. Neuropsychopharmacol. 23, 762\u2013773. 10.1093/ijnp/pyaa060", "ArticleIdList": ["10.1093/ijnp/pyaa060", "PMC7745250", "32761175"]}, {"Citation": "Saijo K., Winner B., Carson C. T., Collier J. G., Boyer L., Rosenfeld M. G., et al. (2009). A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 137, 47\u201359. 10.1016/j.cell.2009.01.038", "ArticleIdList": ["10.1016/j.cell.2009.01.038", "PMC2754279", "19345186"]}, {"Citation": "Sakina M., Dandiya P. J. F. (1990). A psycho-neuropharmacological profile of Centella asiatica extract. Fitoterapia 61, 291\u2013296. 10.1016/j.fitote.2022.105163", "ArticleIdList": ["10.1016/j.fitote.2022.105163"]}, {"Citation": "Salem M. A., El-Shiekh R. A., Fernie A. R., Alseekh S., Zayed A. (2022). Metabolomics-based profiling for quality assessment and revealing the impact of drying of Turmeric (Curcuma longa L.). Sci. Rep. 12, 1\u201311. 10.1038/s41598-022-13882-y", "ArticleIdList": ["10.1038/s41598-022-13882-y", "PMC9206664", "35717541"]}, {"Citation": "Schapira A., Cooper J., Dexter D., Clark J., Jenner P., Marsden C. J. J. o. n. (1990). Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54, 823\u2013827. 10.1111/j.1471-4159.1990.tb02325.x", "ArticleIdList": ["10.1111/j.1471-4159.1990.tb02325.x", "2154550"]}, {"Citation": "Schapira A., Cooper J., Dexter D., Jenner P., Clark J., Marsden C. J. T. L. (1989). Mitochondrial complex I deficiency in Parkinson's disease. Lancet 333, 1269. 10.1016/s0140-6736(89)92366-0", "ArticleIdList": ["10.1016/s0140-6736(89)92366-0", "2566813"]}, {"Citation": "Schapira A. H. J. N. (2006). Etiology of Parkinson's disease. Neurology 66, S10\u2013S23. 10.1212/wnl.66.10_suppl_4.s10", "ArticleIdList": ["10.1212/wnl.66.10_suppl_4.s10", "16717248"]}, {"Citation": "Schapira A. H., Tolosa E. J. N. R. N. (2010). Molecular and clinical prodrome of Parkinson disease: Implications for treatment. Nat. Rev. Neurol. 6, 309\u2013317. 10.1038/nrneurol.2010.52", "ArticleIdList": ["10.1038/nrneurol.2010.52", "20479780"]}, {"Citation": "Schapira A. J. E. (2011). Challenges to the development of disease\u2010modifying therapies in Parkinson\u2019s disease. Eur. J. Neurol. 18, 16\u201321. 10.1111/j.1468-1331.2010.03324.x", "ArticleIdList": ["10.1111/j.1468-1331.2010.03324.x", "21255199"]}, {"Citation": "Schapira A. J. M. D. (1994). Evidence for mitochondrial dysfunction in Parkinson's disease\u2014A critical appraisal. Mov. Disord. 9, 125\u2013138. 10.1002/mds.870090202", "ArticleIdList": ["10.1002/mds.870090202", "8196673"]}, {"Citation": "Schapira A. J. N.(1995). Oxidative stress in Parkinson's disease. Neuropathol. Appl. Neurobiol. 21, 3\u20139. 10.1111/j.1365-2990.1995.tb01022.x", "ArticleIdList": ["10.1111/j.1365-2990.1995.tb01022.x", "7770118"]}, {"Citation": "Schenck C. H., Bundlie S. R., Ettinger M. G., Mahowald M. W. J. S. (1986). Chronic behavioral disorders of human REM sleep: A new category of parasomnia. Sleep 9, 293\u2013308. 10.1093/sleep/9.2.293", "ArticleIdList": ["10.1093/sleep/9.2.293", "3505730"]}, {"Citation": "Schenck C. H., Bundlie S. R., Patterson A. L., Mahowald M. W. J. J., \"Rapid eye movement sleep behavior disorder: A treatable parasomnia affecting older adults, \" vol. 257, pp. 1786\u20131789. 10.1001/jama.1987.03390130104038 1987.", "ArticleIdList": ["10.1001/jama.1987.03390130104038", "3820495"]}, {"Citation": "Schenck C. H., Mahowald M. W. J., Research S. D. (2002). REM sleep behavior disorder: Clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP.", "ArticleIdList": ["11902423"]}, {"Citation": "Schneider R. B., Iourinets J., Richard I. H. J. N. (2017). Parkinson's disease psychosis: Presentation, diagnosis and management. Neurodegener. Dis. Manag. 7, 365\u2013376. 10.2217/nmt-2017-0028", "ArticleIdList": ["10.2217/nmt-2017-0028", "29160144"]}, {"Citation": "Schrag A., Ben-Shlomo Y., Quinn N. J. T. L. (1999). Prevalence of progressive supranuclear palsy and multiple system atrophy: A cross-sectional study. Lancet 354, 1771\u20131775. 10.1016/s0140-6736(99)04137-9", "ArticleIdList": ["10.1016/s0140-6736(99)04137-9", "10577638"]}, {"Citation": "Schupp P., Steube K., Meyer C., Proksch P. J. C. l. (2001). Anti-proliferative effects of new staurosporine derivatives isolated from a marine ascidian and its predatory flatworm. Cancer Lett. 174, 165\u2013172. 10.1016/s0304-3835(01)00694-2", "ArticleIdList": ["10.1016/s0304-3835(01)00694-2", "11689292"]}, {"Citation": "Sengupta T., Vinayagam J., Singh R., Jaisankar P., Mohanakumar K. (2016). \u201cPlant-derived natural products for Parkinson\u2019s disease therapy,\u201d in The benefits of natural products for neurodegenerative diseases (Springer; ), 415\u2013496.", "ArticleIdList": ["27651267"]}, {"Citation": "Shah D., Gandhi M., Kumar A., Cruz-Martins N., Sharma R., Nair S. (2021). Current insights into epigenetics, noncoding RNA interactome and clinical pharmacokinetics of dietary polyphenols in cancer chemoprevention. Crit. Rev. Food Sci. Nutr., 1\u201337. 10.1080/10408398.2021.1968786", "ArticleIdList": ["10.1080/10408398.2021.1968786", "34433338"]}, {"Citation": "Sharma R., Bedarkar P., Timalsina D., Chaudhary A., Prajapati P. K. (2022). Bhavana, an ayurvedic pharmaceutical method and a versatile drug delivery platform to prepare potentiated micro-nano-sized drugs: Core concept and its current relevance. Bioinorg. Chem. Appl., 2597\u20132608. 10.1155/2022/1685393", "ArticleIdList": ["10.1155/2022/1685393", "PMC9076343", "35529314"]}, {"Citation": "Sharma R., Kabra A., Rao M. M., Prajapati P. K. (2018). Herbal and holistic solutions for neurodegenerative and depressive disorders: Leads from Ayurveda. Curr. Pharm. Des. 27 (3), 2597\u20132608. 10.2174/1381612824666180821165741", "ArticleIdList": ["10.2174/1381612824666180821165741", "30147009"]}, {"Citation": "Sharma R., Kuca K., Nepovimova E., Kabra A., Rao M. M., Prajapati P. K. (2019). Traditional Ayurvedic and herbal remedies for Alzheimer's disease from bench to bedside. Expert Rev. Neurother. 19, 359\u2013374. 10.1080/14737175.2019.1596803", "ArticleIdList": ["10.1080/14737175.2019.1596803", "30884983"]}, {"Citation": "Sharma R., Martins N. (2020). Telomeres, DNA damage and ageing: Potential leads from ayurvedic rasayana (Anti-Ageing) drugs. J. Clin. Med. 9 (8), 2544. 10.3390/jcm9082544", "ArticleIdList": ["10.3390/jcm9082544", "PMC7465058", "32781627"]}, {"Citation": "Sharma R., Prajapati P. K. (2020). Predictive, preventive and personalized medicine: Leads from ayurvedic concept of prakriti (human constitution). Curr. Pharmacol. Rep. 6, 441\u2013450. 10.1007/s40495-020-00244-3", "ArticleIdList": ["10.1007/s40495-020-00244-3"]}, {"Citation": "Sharma R., Singla R. K., Banerjee S., Sinha B., Shen B., Sharma R. (2022). Role of Shankhpushpi (Convolvuluspluricaulis) in neurological disorders: An umbrella review covering evidence fromethnopharmacology to clinical studies. Neurosci. Biobehav Rev. 140, 104795. 10.1016/j.neubiorev.2022", "ArticleIdList": ["10.1016/j.neubiorev.2022", "35878793"]}, {"Citation": "Sharma R., Kakodkar P., Kabra A., Prajapati P. K. (2022). Golden ager Chyawanprash with meager evidential base from human clinical trials. Evidence-Based Complementary Altern. Med., 1\u20136. 10.1155/2022/9106415", "ArticleIdList": ["10.1155/2022/9106415"]}, {"Citation": "Sharma S., Awasthi A., Singh S. J. N. (2019). Altered gut microbiota and intestinal permeability in Parkinson's disease: Pathological highlight to management. Neurosci. Lett. 712, 134516. 10.1016/j.neulet.2019.134516", "ArticleIdList": ["10.1016/j.neulet.2019.134516", "31560998"]}, {"Citation": "Shimura H., Hattori N., Kubo S. I., Yoshikawa M., Kitada T., Matsumine H., et al. (1999). Immunohistochemical and subcellular localization of parkin protein: Absence of protein in autosomal recessive juvenile parkinsonism patients. Ann. Neurol. 45, 668\u2013672. 10.1002/1531-8249(199905)45:5<668::aid-ana19>3.0.co;2-z", "ArticleIdList": ["10.1002/1531-8249(199905)45:5<668::aid-ana19>3.0.co;2-z", "10319893"]}, {"Citation": "Shobana C., Ramesh Kumar R., Sumathi T. (2012). Alcoholic extract of bacopa monniera linn. Protects against 6-hydroxydopamine-induced changes in behavioral and biochemical aspects: A pilot study. Cell. Mol. Neurobiol. 32, 1099\u20131112. 10.1007/s10571-012-9833-3", "ArticleIdList": ["10.1007/s10571-012-9833-3", "22527857"]}, {"Citation": "Shu Y.-Z. J. (1998). Recent natural products based drug development: A pharmaceutical industry perspective. J. Nat. Prod. 61, 1053\u20131071. 10.1021/np9800102", "ArticleIdList": ["10.1021/np9800102", "9722499"]}, {"Citation": "Shulman L. M. (2007). Gender differences in Parkinson's disease. Gend. Med. 4, 8\u201318. 10.1016/s1550-8579(07)80003-9", "ArticleIdList": ["10.1016/s1550-8579(07)80003-9", "17584622"]}, {"Citation": "Silva A. H., Fonseca F. N., Pimenta A. T., Lima M. S., Silveira E. R., Viana G. S., et al. (2016). Pharmacognostical analysis and protective effect of standardized extract and rizonic acid from Erythrina velutina against 6-hydroxydopamine-induced neurotoxicity in Sh-Sy5Y cells. Pharmacogn. Mag. 12, 307\u2013312. 10.4103/0973-1296.192200", "ArticleIdList": ["10.4103/0973-1296.192200", "PMC5096278", "27867274"]}, {"Citation": "Simard M., van Reekum R., Cohen T. J. T. J. (2000). A review of the cognitive and behavioral symptoms in dementia with Lewy bodies. J. Neuropsychiatry Clin. Neurosci. 12, 425\u2013450. 10.1176/jnp.12.4.425", "ArticleIdList": ["10.1176/jnp.12.4.425", "11083160"]}, {"Citation": "Singh A. K., Mishra S. K., Mishra G., Maurya A., Awasthi R., Yadav M. K., et al. (2020). Inorganic clay nanocomposite system for improved cholinesterase inhibition and brain pharmacokinetics of donepezil. Drug Dev. Ind. Pharm. 46, 8\u201319. 10.1080/03639045.2019.1698594", "ArticleIdList": ["10.1080/03639045.2019.1698594", "31809608"]}, {"Citation": "Small G. W., Rabins P. V., Barry P. P., Buckholtz N. S., DeKosky S. T., Ferris S. H., et al. (1997). Diagnosis and treatment of alzheimer disease and related disorders: Consensus statement of the American association for geriatric psychiatry. Alzheimer's Assoc. Am. Geriatrics Soc. 278, 1363\u20131371. 10.1001/jama.1997.03550160083043", "ArticleIdList": ["10.1001/jama.1997.03550160083043", "9343469"]}, {"Citation": "Snyder H., Wolozin B. (2004). Pathological proteins in Parkinson's disease: Focus on the proteasome. J. Mol. Neurosci. 24, 425\u2013442. 10.1385/JMN:24:3:425", "ArticleIdList": ["10.1385/JMN:24:3:425", "15655264"]}, {"Citation": "Spillantini M. G., Crowther R. A., Jakes R., Hasegawa M., Goedert M. J. P. (1998). alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc. Natl. Acad. Sci. U. S. A. 95, 6469\u20136473. 10.1073/pnas.95.11.6469", "ArticleIdList": ["10.1073/pnas.95.11.6469", "PMC27806", "9600990"]}, {"Citation": "Stefanis L. J. N. (2016). Alpha-synuclein aggregation and synaptic pathology in Parkinson\u2019s disease and Dementia with Lewy Bodies. Acta Neuropathol. 1, S4.", "ArticleIdList": ["PMC2892607", "20563819"]}, {"Citation": "Steinman R. M. J. (1991). The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9, 271\u2013296. 10.1146/annurev.iy.09.040191.001415", "ArticleIdList": ["10.1146/annurev.iy.09.040191.001415", "1910679"]}, {"Citation": "Steinman R. M. J. T. (2001). Dendritic cells and the control of immunity: Enhancing the efficiency of antigen presentation. Mt. Sinai J. Med. 68, 160\u2013166.", "ArticleIdList": ["11373688"]}, {"Citation": "Stover N. P., Watts R. L. (2001). \u201cCorticobasal degeneration,\u201d in Seminars in neurology, 049\u2013058.", "ArticleIdList": ["11346025"]}, {"Citation": "Su X., Maguire-Zeiss K. A., Giuliano R., Prifti L., Venkatesh K., Federoff H. J. J. N.(2008). Synuclein activates microglia in a model of Parkinson's disease. Neurobiol. Aging 29, 1690\u20131701. 10.1016/j.neurobiolaging.2007.04.006", "ArticleIdList": ["10.1016/j.neurobiolaging.2007.04.006", "PMC2621109", "17537546"]}, {"Citation": "Sudati J. H., Vieira F. A., Pavin S. S., Dias G. R. M., Seeger R. L., Golombieski R., et al. (2013). Valeriana officinalis attenuates the rotenone-induced toxicity in Drosophila melanogaster . Neurotoxicology 37, 118\u2013126. 10.1016/j.neuro.2013.04.006", "ArticleIdList": ["10.1016/j.neuro.2013.04.006", "23639798"]}, {"Citation": "Sugumar M., Sevanan M., Sekar S. J. I. J. (2019). Neuroprotective effect of naringenin against MPTP-induced oxidative stress. Int. J. Neurosci. 129, 534\u2013539. 10.1080/00207454.2018.1545772", "ArticleIdList": ["10.1080/00207454.2018.1545772", "30433834"]}, {"Citation": "Surmeier D. J., Guzman J. N., Sanchez-Padilla J. J. C. (2010). Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease. Cell Calcium 47, 175\u2013182. 10.1016/j.ceca.2009.12.003", "ArticleIdList": ["10.1016/j.ceca.2009.12.003", "PMC3235732", "20053445"]}, {"Citation": "Svensson E., Beiske A. G., Loge J. H., Beiske K. K., Sivertsen B. J. B. n. (2012). Sleep problems in Parkinson\u2019s disease: A community-based study in Norway. BMC Neurol. 12, 71\u201376. 10.1186/1471-2377-12-71", "ArticleIdList": ["10.1186/1471-2377-12-71", "PMC3472275", "22883600"]}, {"Citation": "Takeuchi T., Ogawa K., Iinuma H., Suda H., Ukita K., Nagatsu T., et al. (1973). Monoamine oxidase inhibitors isolated from fermented broths. J. Antibiot. 26, 162\u2013167. 10.7164/antibiotics.26.162", "ArticleIdList": ["10.7164/antibiotics.26.162", "4798774"]}, {"Citation": "Tansey M. G., McCoy M. K., Frank-Cannon T. C. J. E. (2007). Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention. Exp. Neurol. 208, 1\u201325. 10.1016/j.expneurol.2007.07.004", "ArticleIdList": ["10.1016/j.expneurol.2007.07.004", "PMC3707134", "17720159"]}, {"Citation": "Tellier J. M., Kalejs N. I., Leonhardt B. S., Cannon D., H\u04e7\u04e7k T. O., Collingsworth P. D. (2022). Widespread prevalence of hypoxia and the classification of hypoxic conditions in the Laurentian Great Lakes. J. Gt. Lakes. Res. 48, 13\u201323. 10.1016/j.jglr.2021.11.004", "ArticleIdList": ["10.1016/j.jglr.2021.11.004"]}, {"Citation": "Tofaris G. K., Razzaq A., Ghetti B., Lilley K. S., Spillantini M. G. J. J. B. C. (2003). Ubiquitination of \u03b1-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function. J. Biol. Chem. 278, 44405\u201344411. 10.1074/jbc.M308041200", "ArticleIdList": ["10.1074/jbc.M308041200", "12923179"]}, {"Citation": "Togasaki D. M., Tanner C. M. J. A. (2000). Epidemiologic aspects. Adv. Neurol. 82, 53\u201359.", "ArticleIdList": ["10624470"]}, {"Citation": "Tomlinson C. L., Patel S., Meek C., Herd C. P., Clarke C. E., Stowe R., et al. (2013). Physiotherapy versus placebo or no intervention in Parkinson's disease.", "ArticleIdList": ["PMC7120224", "24018704"]}, {"Citation": "Tsai S.-T., Lin S.-H., Chou Y.-C., Pan Y.-H., Hung H.-Y., Li C.-W., et al. (2009). Prognostic factors of subthalamic stimulation in Parkinson\u2019s disease: A comparative study between short-and long-term effects. Stereotact. Funct. Neurosurg. 87, 241\u2013248. 10.1159/000225977", "ArticleIdList": ["10.1159/000225977", "19556833"]}, {"Citation": "Uberti D., Carsana T., Francisconi S., Toninelli G. F., Canonico P. L., Memo M. J. B. (2004). A novel mechanism for pergolide-induced neuroprotection: Inhibition of NF-kappaB nuclear translocation. Biochem. Pharmacol. 67, 1743\u20131750. 10.1016/j.bcp.2004.01.012", "ArticleIdList": ["10.1016/j.bcp.2004.01.012", "15081873"]}, {"Citation": "Ugen K. E., Lin X., Bai G., Liang Z., Cai J., Li K., et al. (2015). Evaluation of an \u03b1 synuclein sensitized dendritic cell based vaccine in a transgenic mouse model of Parkinson disease. Hum. Vaccin. Immunother. 11, 922\u2013930. 10.1080/21645515.2015.1012033", "ArticleIdList": ["10.1080/21645515.2015.1012033", "PMC4514430", "25714663"]}, {"Citation": "Vitek J. L., Bakay R. A., Freeman A., Evatt M., Green J., McDonald W., et al. (2003). Randomized trial of pallidotomy versus medical therapy for Parkinson's disease. Ann. Neurol. 53, 558\u2013569. 10.1002/ana.10517", "ArticleIdList": ["10.1002/ana.10517", "12730989"]}, {"Citation": "Wang Y.-M., Cui Q.-F., Zhao W.-L., Zhang J.-Y., Wang H.-Q. J. B. (2014). \"Nrf2/ARE/HO-1 signaling pathway is a new neuroprotective target for Parkinson\u2019s disease, Front. Pharmacol., \" 34, 1125."}, {"Citation": "Wakita S., Izumi Y., Nakai T., Adachi K., Takada-Takatori Y., Kume T., et al. (2014). Staurosporine induces dopaminergic neurite outgrowth through AMP-activated protein kinase/mammalian target of rapamycin signaling pathway. Neuropharmacology 77, 39\u201348. 10.1016/j.neuropharm.2013.09.012", "ArticleIdList": ["10.1016/j.neuropharm.2013.09.012", "24067927"]}, {"Citation": "Wang J., Yang Q. X., Sun X., Vesek J., Mosher Z., Vasavada M., et al. (2015). MRI evaluation of asymmetry of nigrostriatal damage in the early stage of early-onset Parkinson's disease. Park. Relat. Disord. 21, 590\u2013596. 10.1016/j.parkreldis.2015.03.012", "ArticleIdList": ["10.1016/j.parkreldis.2015.03.012", "25825242"]}, {"Citation": "Wang L. M., Han Y. F., Tang X. C. J. E. (2000). Huperzine A improves cognitive deficits caused by chronic cerebral hypoperfusion in rats. Eur. J. Pharmacol. 398, 65\u201372. 10.1016/s0014-2999(00)00291-0", "ArticleIdList": ["10.1016/s0014-2999(00)00291-0", "10856449"]}, {"Citation": "Wang X., Cong P., Liu Y., Tao S., Chen Q., Wang J., et al. (2018). Neuritogenic effect of sea cucumber glucocerebrosides on NGF-induced PC12 cells via activation of the TrkA/CREB/BDNF signalling pathway. J. Funct. Foods 46, 175\u2013184. 10.1016/j.jff.2018.04.035", "ArticleIdList": ["10.1016/j.jff.2018.04.035"]}, {"Citation": "Wanneveich M., Moisan F., Jacqmin\u2010Gadda H., Elbaz A., Joly P. (2018). Projections of prevalence, lifetime risk, and life expectancy of Parkinson's disease (2010\u20102030) in France. Mov. Disord. 33, 1449\u20131455. 10.1002/mds.27447", "ArticleIdList": ["10.1002/mds.27447", "30145805"]}, {"Citation": "Warner T. T., Schapira A. H., (2003). Genetic and environmental factors in the cause of Parkinson's disease. Ann. Neurol. 53, S16\u2013S25. 10.1002/ana.10487", "ArticleIdList": ["10.1002/ana.10487", "12666095"]}, {"Citation": "Watanabe H., Saito Y., Terao S., Ando T., Kachi T., Mukai E., et al. (2002). Progression and prognosis in multiple system atrophy: An analysis of 230 Japanese patients. Brain 125, 1070\u20131083. 10.1093/brain/awf117", "ArticleIdList": ["10.1093/brain/awf117", "11960896"]}, {"Citation": "Weaver F. M., Follett K., Stern M., Hur K., Harris C., Marks W. J., et al. \"Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: A randomized controlled trial, \" vol. 301, pp. 63\u201373. 10.1001/jama.2008.929 2009.", "ArticleIdList": ["10.1001/jama.2008.929", "PMC2814800", "19126811"]}, {"Citation": "Wenning G., Litvan I., Jankovic J., Granata R., Mangone C., McKee A., et al. (1998). Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J. Neurol. Neurosurg. Psychiatry 64, 184\u2013189. 10.1136/jnnp.64.2.184", "ArticleIdList": ["10.1136/jnnp.64.2.184", "PMC2169933", "9489528"]}, {"Citation": "Williamson T. P. (2012). Activation of the Nrf2-ARE pathway as a therapeutic strategy in Parkinson's disease. The University of Wisconsin-Madison."}, {"Citation": "Wilms H., Rosenstiel P., Sievers J., Deuschl G., Zecca L., Lucius R. J. T. F. (2003). Activation of microglia by human neuromelanin is NF\u2010\u03baB\u2010dependent and involves p38 mitogen\u2010activated protein kinase: Implications for Parkinson's disease. FASEB J. 17, 1\u201320. 10.1096/fj.02-0314fje", "ArticleIdList": ["10.1096/fj.02-0314fje", "12631585"]}, {"Citation": "Wu Y., Shang Y., Sun S., Liang H., Liu R. J. A. (2007). Erythropoietin prevents PC12 cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis via the Akt/GSK-3beta/caspase-3 mediated signaling pathway. Apoptosis 12, 1365\u20131375. 10.1007/s10495-007-0065-9", "ArticleIdList": ["10.1007/s10495-007-0065-9", "17508273"]}, {"Citation": "Xiao X. Q., Zhang H. Y., Tang X. C. J. J. (2002). Huperzine A attenuates amyloid \u03b2\u2010peptide fragment 25\u201035\u2010induced apoptosis in rat cortical neurons via inhibiting reactive oxygen species formation and caspase\u20103 activation. J. Neurosci. Res. 67, 30\u201336. 10.1002/jnr.10075", "ArticleIdList": ["10.1002/jnr.10075", "11754078"]}, {"Citation": "Xilouri M., Stefanis L. J. (2011). Autophagic pathways in Parkinson disease and related disorders. Expert Rev. Mol. Med. 13. 10.1017/S1462399411001803", "ArticleIdList": ["10.1017/S1462399411001803", "21418705"]}, {"Citation": "Xilouri M., Vogiatzi T., Stefanis L. J. A. (2008). alpha-synuclein degradation by autophagic pathways: a potential key to Parkinson\u2019s disease pathogenesis. Autophagy 4, 917\u2013919. 10.4161/auto.6685", "ArticleIdList": ["10.4161/auto.6685", "18708765"]}, {"Citation": "Xu J., Guo S., Du L., Wang Y.-M., Sugawara T., Hirata T., et al. (2013). Isolation of cytotoxic glucoerebrosides and long-chain bases from sea cucumber Cucumaria frondosa using high speed counter-current chromatography. J. Oleo Sci. 62, 133\u2013142. 10.5650/jos.62.133", "ArticleIdList": ["10.5650/jos.62.133", "23470440"]}, {"Citation": "Yadav S., Dixit A., Agrawal S., Singh A., Srivastava G., Singh A. K., et al. (2012). Rodent models and contemporary molecular techniques: Notable feats yet incomplete explanations of Parkinson\u2019s disease pathogenesis. Mol. Neurobiol. 46, 495\u2013512. 10.1007/s12035-012-8291-8", "ArticleIdList": ["10.1007/s12035-012-8291-8", "22736079"]}, {"Citation": "Yuan H., Zhang Z.-W., Liang L.-W., Shen Q., Wang X.-D., Ren S.-M., et al. (2010). Treatment strategies for Parkinson\u2019s disease. Neurosci. Bull. 26, 66\u201376. 10.1007/s12264-010-0302-z", "ArticleIdList": ["10.1007/s12264-010-0302-z", "PMC5552548", "20101274"]}, {"Citation": "Yuan J. P., Peng J., Yin K., Wang J. H. J. M., research f. (2011). Potential health\u2010promoting effects of astaxanthin: A high\u2010value carotenoid mostly from microalgae. Mol. Nutr. Food Res. 55, 150\u2013165. 10.1002/mnfr.201000414", "ArticleIdList": ["10.1002/mnfr.201000414", "21207519"]}, {"Citation": "Yuan K., Li X., Lu Q., Zhu Q., Jiang H., Wang T., et al. (2019). Application and mechanisms of triptolide in the treatment of inflammatory diseases\u2014A review. Front. Pharmacol. 10, 1469. 10.3389/fphar.2019.01469", "ArticleIdList": ["10.3389/fphar.2019.01469", "PMC6908995", "31866868"]}, {"Citation": "Zhai A., Zhang Y., Zhu X., Liang J., Wang X., Lin Y., et al. (2011). Secalonic acid A reduced colchicine cytotoxicity through suppression of JNK, p38 MAPKs and calcium influx. Neurochem. Int. 58, 85\u201391. 10.1016/j.neuint.2010.10.016", "ArticleIdList": ["10.1016/j.neuint.2010.10.016", "21073911"]}, {"Citation": "Zhang H., Bai L., He J., Zhong L., Duan X., Ouyang L., et al. (2017). Recent advances in discovery and development of natural products as source for anti-Parkinson's disease lead compounds. Eur. J. Med. Chem. 141, 257\u2013272. 10.1016/j.ejmech.2017.09.068", "ArticleIdList": ["10.1016/j.ejmech.2017.09.068", "29031072"]}, {"Citation": "Zhang H., Bai L., He J., Zhong L., Duan X., Ouyang L., et al. (2017). Recent advances in discovery and development of natural products as source for anti-Parkinson's disease lead compounds. Eur. J. Med. Chem. 141, 257\u2013272. 10.1016/j.ejmech.2017.09.068", "ArticleIdList": ["10.1016/j.ejmech.2017.09.068", "29031072"]}, {"Citation": "Zhang J., Wei L., Hu X., Xie B., Zhang Y., Wu G.-R., et al. (2015). Akinetic-rigid and tremor-dominant Parkinson's disease patients show different patterns of intrinsic brain activity. Park. Relat. Disord. 21, 23\u201330. 10.1016/j.parkreldis.2014.10.017", "ArticleIdList": ["10.1016/j.parkreldis.2014.10.017", "25465747"]}, {"Citation": "Zhou J., Fu Y., Tang X. C. J. N. (2001). Huperzine A and donepezil protect rat pheochromocytoma cells against oxygen\u2013glucose deprivation. Neurosci. Lett. 306, 53\u201356. 10.1016/s0304-3940(01)01855-9", "ArticleIdList": ["10.1016/s0304-3940(01)01855-9", "11403956"]}, {"Citation": "Zhu G., Wang X., Chen Y., Yang S., Cheng H., Wang N., et al. (2010). Puerarin protects dopaminergic neurons against 6-hydroxydopamine neurotoxicity via inhibiting apoptosis and upregulating glial cell line-derived neurotrophic factor in a rat model of Parkinson's disease. Planta Med. 76, 1820\u20131826. 10.1055/s-0030-1249976", "ArticleIdList": ["10.1055/s-0030-1249976", "20509103"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "6", "Day": "23"}, {"Year": "2022", "Month": "9", "Day": "21"}, {"Year": "2022", "Month": "10", "Day": "27", "Hour": "2", "Minute": "38"}, {"Year": "2022", "Month": "10", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "10", "Day": "28", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "10", "Day": "6"}], "PublicationStatus": "epublish", "ArticleIdList": ["36299886", "PMC9590378", "10.3389/fphar.2022.976385", "976385"]}}], "PubmedBookArticle": []}